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Angiogenesis is critical to most physiological processes and many pathological 
conditions. This process is controlled by physical interactions between the extracellular 
matrix (ECM) and endothelial cells. Klf2, a blood flow–sensitive transcription factor, 
promotes VEGF-dependent angiogenesis during zebrafish cardiovascular development. 
However, the mechanism by which biophysical stimuli regulate Klf2 expression and 
control angiogenesis remains largely unknown.  
In my study, I show that elevated klf2 mRNA levels underlie the molecular and 
morphogenetic cardiovascular defects in zebrafish ccm mutants. Furthermore, I 
demonstrate that these defects are mediated by enhanced egfl7 expression and 
angiogenesis signaling. My study also revealed that Klf2 expression is regulated by the 
extracellular matrix-binding receptor β1 integrin in the absence of blood flow. The 
CCM protein complex and its associated β1 integrin-regulatory protein ICAP-1 
prevents increased angiogenesis signaling in endothelial cells by limiting β1 integrin-
mediated expression of Klf2.  
ln sum, my work uncovered a novel β1 integrin-Klf2-Egfl7 signaling pathway, which is 








Angiogenese ist entscheidend für die meisten physiologische Prozesse und viele 
pathologische Umstände. Dabei wird Angiogenese durch die Interaktion zwischen der 
extrazellulären Matrix (ECM) und endothelialen Zellen reguliert. Während der 
kardiovaskulären Entwicklung im Zebrafisch fördert Klf2, ein blutstrom-sensitiver 
Transkriptionsfaktor, die VEGF-abhängige Angiogenese. Der Mechanismus, bei dem 
biophysikalische Reize die Klf2 Expression regulieren und Angiogenese kontrollieren, 
ist größtenteils unbekannt. 
In meiner Studie zeige ich, dass erhöhte klf2 mRNA Expression den molekularen und 
morphogenetischen kardiovaskulären Defekten in Zebrafisch ccm Mutanten 
zugrundeliegen. Desweiteren zeige ich, dass diese Defekte durch verstärkte egfl7-
Expression und Angiogenese vermittelt werden. Meine Studie zeigt ausserdem, dass die 
Klf2-Expression unabhängig vom Blutstrom durch den Extrazellularmatrix-bindenden 
Rezeptor β1 Integrin reguliert wird. Der CCM-Protein-Komplex, zusammen mit dem 
ihm verbundenden Integrin-regulierenden Protein ICAP-1 verhindert ein verstärktes 
Angiogenese-Signal in endothelialen Zellen, indem es die β1 Integrin-abhängige Klf2 
Expression begrenzt. 
Zusammenfassend	   zeigt	   meine	   Arbeit	   einen	   neuen	   β1 Integrin-Klf2-Egfl7 








1.1 Cerebral Cavernous Malformation  
 
1.1.1 CCM proteins in the human pathology 
 
Cerebral cavernous malformations (CCMs) are vascular lesions within low blood flow 
venous capillary beds. They are characterized by mulberry-like clusters of thin-walled, 
enlarged blood vessels arranged to densely packed sinusoids without intervening neural 
parenchyma (Introduction Fig. 1) (Fischer et al., 2013). Ultrastructural analyses of 
CCMs revealed ruptures and damages in the luminal endothelium due to a lack of 
endothelial junctions and detachements between the endothelium and basal lamina. 
Furthermore, these lesions lack supporting subendothelial cells such as smooth muscle 
cells, elastic tissue, or astrocytic foot processes (Clatterbuck et al., 2001; Tanriover et 
al., 2013). Primarily, CCMs are found within the neurovasculature of the central 
Introduction Figure 1 
Magnetic Resonance Imaging (MRI) of multiple cerebral cavernous 




nervous system, where they can cause headaches, seizure, and neurological deficits 
caused by cerebral hemorrhages (Dobyns et al., 1987; Gil-Nagel et al., 1995), but they 
can also occur in the skin (Eerola et al., 2000; Labauge et al., 1999). 
CCMs have a prevalence of approximately 0,5% of the entire population (Otten et 
al., 1989). CCMs may occur in both sporadic or familial forms. The sporadic form 
accounts for 80% of CCMs and is mostly associated with a single CCM formation. In 
contrast, most of the familial cases develop multiple CCMs (Krisht et al., 2010; Riant et 
al., 2010). Familial CCMs are autosomal-dominant and are associated with 
heterozygous germline loss-of-function due to a mutation in at least one of the three 
genes, CCM1 (Laberge-le Couteulx et al., 1999; Sahoo et al., 1999), CCM2 (Denier et 
al., 2004; Liquori et al., 2003), or CCM3 (Bergametti et al., 2005). A „second hit“, or 
Knudsonian mutation is needed for a somatic loss-of-function of the second allele 
(Akers et al., 2009; Gault et al., 2005; Pagenstecher et al., 2009). The total loss-of-
function of any of these genes may then result in CCM lesions. 
 
1.1.2 Structure and functions of CCM proteins 
 
1.1.2.1 KRIT1 (Krev interaction trapped 1)/ CCM1 
 
In human and mouse, KRIT1 is a 736 amino acid protein that consists of a N-terminal 
Nudix domain, three canonical NPxY/F motifs and a C-terminal FERM (band 4.1, 
ezrin, radixin, moesin) domain (Introduction Fig. 2) (Gingras et al., 2013; Li et al., 
2012; Liu et al., 2013). It was identified in a yeast two-hybrid screen as an interaction 
partner of the small GTPase Krev-1 (Rap1) (Serebriiskii et al., 1997). During early 
embryogenesis, KRIT1 is broadly expressed with a preference to endothelial cells 
(Guzeloglu-Kayisli et al., 2004). Intracellularly, KRIT1 was found in different cellular 
compartments, including cell-cell junctions in endothelial cells (Glading et al., 2007; 
Zawistowski et al., 2005). The subcellular localization of KRIT1 appears to be 
dependent on its conformational organization (Beraud-Dufour et al., 2007; Francalanci 
et al., 2009). It has been suggested that intramolecular binding of the NPxY/F motifs 
with its FERM domain results in a „closed“ conformation which allows KRIT1 to bind 
to microtubules (Beraud-Dufour et al., 2007). KRIT1 is then transported along 
Introduction 
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microtubules to the plasma membrane. There, activated Rap1 binds to KRIT1 and 
causes an „open“ conformation thereby enabling the relocalization of KRIT1 to the 
membrane and the stabilization of adherence junctions (Liu et al., 2011). Junctional 
stability is achived by the association of KRIT1 with components of the adherence 
junctions (β-catenin, α-catenin, VE-cadherin, AF 6 and p120-catenin) (Glading et al., 
2007). Loss of KRIT1 results in a translocation of β-catenin to the nucleus and a 
transcriptional up-regulation of β-catenin target genes. Rap1 binding stabilizes KRIT1 
and prevents the dissociation of β-catenin from the junctional complex (Introduction 
Fig. 7) (Glading et al., 2010). In zebrafish, knock-down of Rap1b leads to intracranial 
hemorrhage due to damaged endothelial junctions. Intriguingly, combinatorial minor 
reduction of Rap1b and Krit1 results in intracranial hemorrhage, indicating that both 
genes act in a common pathway (Gore et al., 2008). However, proteomic analysis 
showed that Rap1 was not found in the CCM complex suggesting that KRIT1 and Rap1 
act in an independent complex (Hilder et al., 2007). In addition, loss of KRIT1 resulted 
in defective endothelial cell polarity by impairing localization of the TIAM-PAR3-
PKCζ complex, vascular lumen formation, and directed cell migration (Lampugnani et 
al., 2010). These findings are similiar to human vascular lesions, where endothelial cells 
are loosely connected to each other (Clatterbuck et al., 2001).  
Several lines of evidences suggested that the formation of CCM lesions could be 
driven by aberrant angiogenesis (Jung et al., 2003). Loss of KRIT1 reduces the 
Introduction Figure 2 
Structural domains and interaction partners of KRIT1/CCM1. Krit1 comprises 
a C-terminal FERM (band 4.1, ezrin, radixin, moesin) domain and three N-terminal 
NPXY/F motifs. ANK: Ankyrin domain, NLS: Nuclear Localization Signal, MT: 




expression of the Notch target genes DLL4, HEY1, and HEY2 and leads to enhanced 
sprouting formation in endothelial cells (Wustehube et al., 2010). Conversely, KRIT1 
overexpression leads to increased expression of HEY1 and DLL4, arguing for a 
modulation of angiogenesis by a KRIT1-Notch signaling cascade. 
Another binding partner of KRIT1 is the integrin cytoplasmic domain associated 
protein-1 (ICAP-1) (Introduction Fig. 3). ICAP-1 is a negative regulator of β1 integrin 
signaling (Liu et al., 2013; Millon-Fremillon et al., 2008). New data shows that KRIT1 
stabilizes ICAP-1 in endothelial cells and prevents increased β1 integrin signaling. 
ICAP-1 levels are reduced upon loss of KRIT1 resulting in increased β1 integrin 
activation and actin stress fiber formation (Faurobert et al., 2013). Conversely, KRIT1 
and the cytoplasmic tail of β1 integrin compete for the same binding site of ICAP-1. 
Hence, binding of KRIT1 to ICAP-1 prevents the inhibition of β1 integrin activation 
(Liu et al., 2013).  
Blood vessels in CCM lesions are frequently characterized by a loss of junctional 
stability, vessel integrity, loss of cell polarity, and increased endothelial cell 
proliferation. These are hallmarks of a process known as endothelial-mesenchymal 
transition (EndMT). Recent data showed that the loss of KRIT1 or PDCD10 (CCM3) 
results in EndMT due to inreased BMP6-SMAD signaling in endothelial cells 
(Maddaluno et al., 2013). Intriguingly, this signaling pathway is also up-regulated in 
human patient material with a loss of KRIT1 or CCM2 (Maddaluno et al., 2013). 
Introduction Figure 3 
Structural domains and interaction partners of ICAP-1. ICAP-1 bears a Ser/Thr 
riche N-terminal NLS motif and phosphorylation sites for Calmodulin-dependent 
kinase II, Protein kinase A and C. (adapted from Faurobert and Albiges-Rizo, 2010) 
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1.1.2.2 CCM2/ Malcavernin 
 
CCM2 consists of a N-terminal PTB domain (Liquori et al., 2003) and C-terminal 
harmonin-homology domain (HHD) (Introduction Fig. 4) (Fischer et al., 2013) and was 
identified in a yeast two-hybrid screen as a scaffold for the MEKK3/MKK3 complex 
(Uhlik et al., 2003). The MEKK3/MKK3 complex is required to restore cell volume and 
morphology upon osmotic shock by activation of its downstream target p38 MAPK. 
P38 MAPK activates actin reorganization and stabilization by inducing the F-actin cap 
binding protein HSP27 (Heat Shock Protein 27). Upon osmotic shock, the CCM2-
MEKK3 complex is recruited to membrane ruffles to interact with Rac1 and F-actin. 
Therefore, the CCM2-MEKK3 complex reorganizes actin polymerization in a RAC1-
dependent manner (Uhlik et al., 2003). Proteomic analysis revealed a direct interaction 
between CCM2, Rac and MEKK3 (Hilder et al., 2007). Interestingly, the loss of CCM2 
does not the affect p38 MAPK pathway, but rather the JNK (c-Jun N-terminal kinase), 
MKK4, MKK7 pathway (Whitehead et al., 2009). Reduction of CCM2 transcript levels 
increased the phosphorylation of JNK and its upstream targets MKK4 and MKK7 via 
increased RhoA levels. Intriguingly, elevated RhoA levels are a common feature after 
RNA-interference-mediated knock-down of any of the CCM proteins (Crose et al., 
2009; Glading et al., 2007; Stockton et al., 2010; Whitehead et al., 2009) and inhibition 
of RhoA-ROCK signaling abolished RhoA-dependent actin stress fiber formation in 
heterozygous Krit1 or Ccm2 mice, and CCM-deficient cells (Borikova et al., 2010; 
Stockton et al., 2010; Whitehead et al., 2009). Co-immunoprecipitation assays showed 
that CCM2 interacts with the E3 ubiquitin ligase Smad ubiquitin regulatory factor 1 
Introduction Figure 4 
Structural domains and interaction partners of CCM2. The CCM2 
PTB domain interacts with a Krit1 NPXY/F motif. (adapted from 
Faurobert and Albiges-Rizo, 2010) 	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(SMURF1) through a PTB/NPXY interaction. This interaction leads to proteosomal 
RhoA degradation required for normal endothelial cell function (Crose et al., 2009). 
Besides direct interaction of CCM2 with Rac1 and RhoA, it has been suggested that 
CCM2 is also involved in Cdc42 activation during vascular lumenization (Kleaveland et 
al., 2009; Whitehead et al., 2009). Cdc42 and Rac1 mediate lumen formation via the 
regulation of components of the cytoskeletal signaling (Pak2 and Pak4), and the cell 
polarity complex (Par3 and Par6) (Koh et al., 2008). CCM2 loss-of-function studies in 
zebrafish and mice revealed a failure of vascular lumen formation, although vacuoles 
are normally formed in the intersegmental vessels in zebrafish. In contrast, CCM2-
depleted HUVECs exhibit decreased numbers of vacuoles and lumen formation in a 3D 
in vitro culture (Whitehead et al., 2009). These results imply that CCM2 acts at 
different levels in vascular lumen formation. Further investigations are needed to solve 
these conflicting results. 
As mentioned above, KRIT1 and ICAP-1 complexes in the regulation of β1 integrin 
dependent stress fiber formation (Introduction Fig. 7). Since KRIT1 and ICAP-1 have a 
NLS motif, both are able to shuttle between the nucleus and the cytosol and activate 
transcriptional programs and cellular proliferation (Fournier et al., 2005; Francalanci et 
al., 2009; Zawistowski et al., 2005). In vitro assays showed that CCM2 can bind to 
KRIT1-ICAP-1 in a ternary complex to inhibit the nuclear translocation of KRIT1-
ICAP-1 (Francalanci et al., 2009; Zawistowski et al., 2005) and therefore transcriptional 
activation of downstream target genes. 
It has been shown that CCM2 induces cell death in neuroblastoma or 
medullablastoma by binding to the receptor tyrosine kinase TrkA in nerve cells (Harel 
et al., 2009) and subsequently recruiting a complex composed of CCM3/PDCD10 and 
STK25 (Costa et al., 2012). 
The identification of CCM2-like (CCM2L), a CCM2 paralogue, allowed further 
insights into the role of CCM proteins in cardiovascular developement (Zheng et al., 
2012). CCM2L is expressed in activated endothelial cells during cardiovascular 
development. Loss of CCM2L reduced endocardial growth factor expression and 
phenocopied the zebrafish Ccm2 phenotype. Overexpression of CCM2 partially rescues 
the CCM2L phenotype (Rosen et al., 2013). Moreover, CCM2L completely blocks 
CCM2-mediated junctional stability and competes with CCM2 for binding to KRIT1. 
Introduction 
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The contribution of CCM2L in human CCM pathology is still unknown and needs to be 
elucidated. 
 
1.1.2.3 CCM3/ PDCD10 (Programmed cell death 10) 
 
In human, CCM3 is a 212 amino acid protein that consists of a N-terminal dimerization 
domain (Introduction Fig. 5) (Kean et al., 2011; Li et al., 2010) and a C-terminal focal 
adhesion targeting-homology (FAT-H) domain. (Li et al., 2010). CCM3 can interact 
with CCM2 with its FAT-H domain to build the ternary KRIT1-CCM2-CCM3 complex 
(Hilder et al., 2007). Furthermore, CCM3 heterodimerizes with several members of the 
germinal center kinase III protein family, including MST4/MASK, STK24/MST3 and 
STK25/YSK1/SOK1 (Sugden et al., 2013; Xu et al., 2013; Zhang et al., 2013a) within 
the striating interacting phosphatase and kinase (STRIPAK) complex to promote Golgi 
assembly and polarization (Fidalgo et al., 2010; Kean et al., 2011). CCM3-depletion in 
SaOS2 cells impaired directed cell migration due to a failure of correct Golgi 
repositioning towards the leading edge (Fidalgo et al., 2010). Recent studies discovered 
that CCM3 plays also a role in exocytosis. Loss of CCM3 or STK24 resulted in 
increased exocytosis of neutrophils due to a loss of interaction with UNC13 (Zhang et 
al., 2013b). In Drosophila, loss of CCM3 or GCKIII kinase resulted in dilated tracheal 
tubes (Song et al., 2013). These studies imply that defective lumen formation and 
vascular morphology in CCM pathology is in part caused by abnormal exocytosis.  
Introduction Figure 5 
Structural domains and interaction partners of CCM3. CCM3 
interacts with MST4, STK24, STK25, and CCM2. (adapted from 
Faurobert and Albiges-Rizo, 2010)	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CCM3-MST4 interaction has also been shown to be important in vascular cell 
polarity and junctional stability. Lkb1 is a tumor supressor gene and seems to control 
the subcellular localization of MST4 (ten Klooster et al., 2009), whereas CCM3 might 
regulate MST4 kinase activity (Ma et al., 2007). Loss of Lkb1 in endothelial cells leads 
to a marked reduction of vascular smooth muscle cells (vSMCs) and disruption of the 
vasculature due to a loss of TGFβ signaling in endothelial cells (Londesborough et al., 
2008). 
There is conflicting data on the function of CCM3: CCM3 promotes cell survival by 
binding to VEGFR2. Loss of CCM3 led to decreased VEGFR2 protein levels and to 
endocytosis of VEGFR2 after VEGF stimulation (He et al., 2010). In contrast, the loss 
of CCM3 increased cell survival and proliferation through increased VEGF signaling, 
inhibition of Notch signaling, or increased ERK activation (Louvi et al., 2011; You et 
al., 2013; Zhu et al., 2010). In zebrafish, which has two Ccm3 isoforms, it has been 
demonstrated that Ccm3-mediated signaling through Ste20-like kinases is involved in 
cardiovascular development (Zheng et al., 2010), and that CCM3 functions in a distinct 
manner from CCM1 and CCM2 (Yoruk et al., 2012). Indeed, neuronal-specific deletion 
of CCM3, but not CCM1 or CCM2, in mouse embryos resulted in vascular defects 
comparable to endothelial-specific knock-out of CCM1, CCM2, or CCM3 (Boulday et 
al., 2009; Boulday et al., 2011; Cunningham et al., 2011; Louvi et al., 2011). These 




Heart-of-glass (HEG1) is a transmembrane protein which is specifically expressed in 
endothelial and endocardial cells (Kleaveland et al., 2009). It contains an extracellular 
domain with two EGF-like repeats, a transmembrane region, and a cytoplasmic C-
terminal NPXY/F domain within its short intracellular part (Introduction Fig. 6). Its 
only known binding partner is KRIT1. Since, loss of heg1 in zebrafish results in the 
same cardiovascular defects as the loss of krit1/ccm1 or ccm2 (Kleaveland et al., 2009; 
Mably et al., 2003; Mably et al., 2006), it has been proposed that these three genes act 
in a common pathway. Biochemical analyses demonstrated that HEG1, KRIT1, and 
CCM2 can bind in a ternary complex (Kleaveland et al., 2009). HEG1-KRIT1 binding 
Introduction 
21 
occurs through the interaction of the HEG1 NPXY/F domain and the KRIT1 FERM 
domain. Structural anaylses also showed that KRIT1 is able to simultaneously bind 
HEG1 and Rap1 via its FERM domain. Thus, HEG1 could act as an anchor protein that 
can recruit the Rap1-KRIT1 complex to the plasma membrane (Gingras et al., 2013). 
Since human patients with CCMs do not have mutations in HEG1, its role in this 
diesease is largely unknown. 
Introduction Figure 7 
Molecular pathways of CCM proteins (adapted from Storkebaum et al., 2011) 
Introduction Figure 6 
Structural domains and interaction partners of HEG1. HEG1 carries two extracellular 
EGF-like repeats and interacts with Krit1 via its C-terminal NPXY/F motif. (adapted from 
Faurobert and Albiges-Rizo, 2010)	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1.2 Cardiovascular development in the zebrafish Danio rerio 
	  
1.2.1 Zebrafish as a model for vertebrate cardiovascular development 
	  
The zebrafish is an excellent model organism to study cardiovascular development, as 
the molecular mechanisms are highly similar to those in humans and other higher 
vertebrates. The eggs are fertilized extrauterinally and have an early stereotyped 
development. Since zebrafish embryos are optically transparent, organogenesis can be 
easily monitored during development. In addition, a variety of genetic and cell 
biological methods are available to manipulate and to investigate cellular processes in 
real time and to uncover the regulatory mechanisms involved in cardiovascular 
development. 
 
1.2.2 Heart development in zebrafish 
 
During vertebrate embryonic development, the heart is the first functional organ to 
form. Although the zebrafish heart has a less complex morphology, with just two heart 
chambers compared to the four chambered mammalian heart, genes responsible for 
essential steps of cardiac development are conserved throughout vertebrate evolution. 
Specification of endocardial and myocardial progenitor cells is the first step in cardiac 
development. Two pools of myocardial progenitor cells at either side in embryos of the 
40% epiboly stage in the lateral marginal zone (Introduction Fig. 8A, Stainier et al., 
1993). Ventricular progenitor cells are located more dorsally in the lateral marginal 
zone compared to atrial progenitor cells (Keegan et al., 2004). Myocardial progenitor 
cell number is restricted by retinoic acid (RA) signaling and the Hox5b transcription 
factor (Keegan et al., 2005; Waxman et al., 2008). Fgf signaling has also been shown to 
act downstream of RA. Retinoic acid signaling restricts the specification of cardiac 
progenitors by regulating Fgf signaling activity (Lin et al., 2010a; Sirbu et al., 2008). In 
contrast, endocardial progenitor cells are distributed throughout the marginal zone 
(Introduction Fig.8A; Keegan et al., 2004). During gastrulation, cardiac progenitor cells 
involute and are finally located in the anterior lateral plate mesoderm (ALPM) at the 
beginning of somitogenesis (Stainier et al., 1993; Warga et al., 1990). 
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Cardiogenic differentiation is initiated at the one- to three-somite stage and requires 
the expression of the homeobox-containing transcription factor Nkx2.5. Nkx2.5 
expression is induced by bone morphogenic protein (Bmp) and Nodal signaling in the 
lateral plate mesoderm via the induction of the transcription factor Gata5 (Kishimoto et 
al., 1997; Reiter et al., 1999).  
At the 14-somite stage myocardial cells start to express sarcomeric genes such as 
myosin light chain polypeptide 7 (myl7) (Introduction Fig. 8B; de Pater et al., 2009; 
Yelon et al., 1999). At the same time, myocardial cells express chamber-specific genes 
and are regionalized in a medial to lateral direction in the ALPM. At the 16-somite 
stage (Introduction Fig. 8C) the bilaterial pools of myocardial cells start to migrate 
toward the embryonic midline and fuse 1 hour later: ventricular myocardial cells fuse 
first along the posterior half and then along the anterior half. The resulting structure is 
called heart cone (Yelon et al., 1999). In contrast to myocardial cells, four-dimensional 
Introduction Figure 8 
Heart development in zebrafish Danio rerio (adapted from Bakkers et al., 2011) 
Introduction 
24 
confocal microscopy has shown that endocardial cells migrate earlier and reach the 
midline at the 16-somite stage (Bussmann et al., 2007).  
Once the heart cone has formed (Introduction Fig. 8D), myocardial cells from the 
right cardiac field involute ventrally and move towards the anterior/left with a 
simultaneous rotation in a clockwise direction (Baker et al., 2008; Bussmann et al., 
2007; Rohr et al., 2008; Smith et al., 2008). As a consequence the heart cone is 
transformed into a tube at 28 hours post fertilization (Introduction Fig. 8E) with its 
arterial pole at the midline and the venous pole at the left side of the embryo. The 
endocardial cells are located within the lumen of the cardiac tube (Baker et al., 2008; 
Bussmann et al., 2007; Rohr et al., 2008). Asymmetric expression of Bmp and Nodal in 
the ALPM direct asymmetric heart morphogenesis (Baker et al., 2008; Smith et al., 
2008; Veerkamp et al., 2013) and myocardial cell polarity and organization are essential 
for heart tube elongation (Rohr et al., 2008; Rohr et al., 2006; Peterson et al., 2001). 
Between 30-48 hours post fertilization (hpf) the linear heart tube bends toward the 
right side and results in a displacement of the ventricle at the right side of the embryonic 
midline, whereas the atrium remains at the left side of the embryonic midline 
(Introduction Fig. 8E-G). Unequal speeds of rotation between the venous pole and 
arterial pole have been suggested to cause a torsion of the heart tube and to result in 
cardiac looping (Smith et al., 2008). During ventricular chamber morphogenesis, 
physical forces generated by blood flow have an impact on myocardial cell shapes and 
chamber ballooning (Auman et al., 2007; Dietrich et al, 2014). 
Blood flow is also required for the formation of cardiac valves between the atrium 
and the ventricle to prevent blood from flowing back from the ventricle to the atrium. In 
amniotes, valve formation starts with a local swelling (cardiac cushions) at the 
atrioventricular canal (AVC). Endocardial cells overlying the local swelling receive a 
myocardial signal, delaminate and migrate into the space between endocardium and 
myocardium. The delamination of these endocardial cells occurs via epithelial-to-
mesenchymal transition (EMT). In zebrafish, cardiac cushion formation starts at 36 hpf 
where specialized squamous endocardial cells at the AVC become cuboidal. These cells 
start to express the cell adhesion molecule Dm-grasp (Beis et al., 2005) and form 
cellular protrusions that extend into the cardiac jelly. In contrast to epithelial-to-
mesenchymal transition in amniote heart valve development (Timmerman et al., 2004), 
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zebrafish endocardial valves arise by invagination of endocardial cells (Scherz et al., 
2008). Although the mechanisms by which heart valves develop differ between 
zebrafish and amniotes, the underlying molecular pathways are conserved. Several 
signaling pathways are involved in valve development including Notch, ErbB, TGFb 
signaling, NFAT, and Wnt-beta-catenin signaling (Beis et al., 2005; Chang et al., 2004; 
Hurlstone et al., 2003; Scherz et al., 2008; Timmerman et al., 2004). Heart valve 
remodelling is also dependent on blood flow, since zebrafish silent heart mutants, 
which lack heart contraction, exhibit impaired valve formation (Bartman et al., 2004). 
Furthermore, expression of the shear stress transcription klf2a has been shown to 
regulate the invagination process of endocardial cells at the AVC by inducing Notch1 
(Dietrich et al., 2014; Vermot et al., 2009). 
 
1.2.3 Vascular development in zebrafish 
 
In all vertebrates, endothelial and hematopoietic cells arise in close association with one 
another during embryonic development. In zebrafish, both cell types develop in the 
intermediate cell mass of the ventral mesoderm, whereas in birds and mammals, these 
cells develop in extraembryonic yolk sac blood islands (Detrich et al., 1995; Haar et al., 
1971; Moore et al., 1965). Despite the spatially distinct manner across the species, they 
share the same genetic programs. During early embryonic development endothelial and 
hematopoietic cells are specified by the expression of stem cell leukemia (scl) and fetal 
liver kinase-1/ vascular endothelial growth factor receptor 2 (flk1/ vegfr2) (Kabrun et 
al., 1997). The fact that both cell lineages express the same genes and develop in close 
association in the primitive lateral mesoderm raised the hypothesis of a common 
precursor cell referred as the hemangioblast. In vivo studies in mice and zebrafish 
provided evidences for the existence of such a cell (Huber et al., 2004; Vogeli et al., 
2006). 
During early somitogenesis endothelial precursor cells (angioblasts) begin to express 
endothelial-specific genes (Fouquet et al., 1997; Kimmel et al., 1990). The expression 
of transcription factors of the ETS gene family can induce the expression of vegfr2 and 
vascular endothelial cadherin (vecdn) (Pham et al., 2007; Sumanas et al., 2006; 
Sumanas et al., 2008). Several studies also demonstrated that the binding of ETS 
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transcription factors with other factors, including members of the Forkhead (FOX) 
family of transcrption factors (De Val et al., 2008) and KLF genes (Meadows et al., 
2009) plays an important role in the specification of endothelial cells. At the 14 somite 
stage, after endothelial cells are specified, they start migrate to the embryonic midline 
above the endoderm. There, the dorsal aorta (DA) and the posterior cardinal vein 
(PCV), the two major trunk axial vessels (Jin et al., 2005; Lawson et al., 2002b) are 
formed de novo by fusion of endothelial cells called angioblasts (vasculogenesis). It has 
been proposed that hypochord-derived soluble Vegf acts as a guidance cue for 
angioblast midline migration (Cleaver et al., 1998; Lawson et al., 2002c) and requires 
the ventral endodermal layer (Jin et al., 2005).  
For a functional circulatory system it is essential that blood vessel acquire a venous 
or arterial identity. Ephrin B2-EphB4 signaling is crucial in this process. EphB4 is 
preferentially expressed in veins, whereas its ligand Ephrin B2 is expressed in arterial 
endothelial cells (Wang et al., 2010c). Additional signaling pathways involved in 
Ephrin-Eph-mediated arterial-venous specification, including Hedgehog, VEGF, and 
Notch signaling. Notch ligands and receptors are exclusively expressed in arterial 
endothelial cells and help to promote arterial differentiation (Lawson et al., 2001; 
Lawson et al., 2002a; Lawson et al., 2003). Notch signaling restricts arterial-specific 
ephrinB2 and venous-specific ephb4 expression. Alterations in sonic hedgehog (shh) or 
vegf activity causes the same arterial-venous specification defects like the loss-of-
function or gain-of-function of Notch signaling (Lawson et al., 2002c; Lawson et al., 
2002a). Shh induces the expression of vegf in the somites, and that vegf then activates 
Notch signaling in endothelial cells of the developing dorsal aorta, resulting in arterial 
differentiation. 
Following the formation of the lateral dorsal aorta and the posterior cardinal vein by 
vasculogenesis, new blood vessels are formed by a process called angiogenesis. During 
angiogenesis, new vessels develop from preexisting vessels. The intersegmental vessels 
(ISVs) of the trunk are the first angiogenic vessels formed in all vertebrates. They 
sprout from the dorsal site of the dorsal aorta and migrate dorsally along vertical somite 
boundaries and interconnect at the dorsal-lateral surface of the neural tube.  
The primary cranial vasculature is established by vasculogenesis of mesodermal-
derived angioblasts. Subsequently, the craniofacial vascular network develops by 
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angiogenesis (Lee et al., 2009). At around 20 hours post fertilization (hpf), angioblasts 
from the lateral plate mesoderm migrate medially as two anterior and posterior cell 
populations to form the paired lateral dorsal aorta (LDA). These vessels are essential to 
provide the arterial supply of blood for the entire head (Isogai et al., 2001). Angiogenic 
growth of the LDA in the caudal direction and the connection with the posterior dorsal 
aorta results in a Y-shaped junction between these vessels (Isogai et al., 2001; 
Siekmann et al., 2009). The primordial hindbrain channels (PHBC) provide the sole 
venous drainage of the head and are also formed by vasculogenesis at the same time as 
the LDA. The basilar artery (BA), the most important artery in the vertebrate head, is 
formed between the PHBCs and the bilateral LDA. The central arteries (CtAs) in the 
hindbrain form later and connect the primordial hindbrain channels and the basilar 
artery. 
Angiogenesis of the cranial vasculature depends on VEGF signaling, as does the ISV 
formation in the trunk region (Covassin et al., 2006). Furthermore Cxcl12b/ cxcr4a 
chemokine signaling is also involved in cranial vascular development (Siekmann et al., 
2009).  
Cord or cell hollowing are thought to be the primary mechanisms controlling 
vascular lumen formation. During this process, lumina form by the creation of fluid-
filled spaces between cells or within single cells (Lubarsky et al., 2003). In vitro studies 
demonstrated that lumen formation requires intracellular vacuolation and intercellular 
fusion of endothelial vacuoles (Bayless et al., 2000; Bayless and Davis, 2002; Kamei et 
al., 2006). These processes are controlled by integrins, Cdc42, Rac, and cell polarity 
complexes (Bayless and Davis, 2002; Davis et al., 1996; Koh et al., 2008). In addition, 
endothelial cells overlap extensively (Blum et al., 2008; Wang et al., 2010b). 
 
1.2.3.1 VEGF-Notch signaling in tip and stalk cell specification during 
angiogenesis 
	  
Blood vessel formation by angiogenesis requires the tight control and coordination of 
endothelial cell behaviour. The hierarchical organization of sprouting endothelial ´tip 
cells´(TCs) and trailing ´stalk cells´(SCs) is a key aspect in branching morphogenesis 
(Introduction Fig. 9). Endothelial tip cells extend long filopodia that sense attractive 
and/or repulsive signals in their environment and direct vascular growth (De Smet et al., 
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2009; Gerhardt et al., 2003). Endothelial stalk cells, that trail TCs are less motile but 
support the extension of the sprouting vessel by cell proliferation. The regulation of tip 
cell and stalk cell specification is directed by VEGF and Notch signaling. VEGFR2 
activation by binding of its ligand VEGFA leads to an up-regulation of the Notch ligand 
Delta-like-4 (DLL4) in tip cells and an activation of Notch signaling in adjacent stalk 
cells, which promotes stalk cell behaviour by lateral inhibition of tip cell fate decision 
(Hellstrom et al., 2007;	    Leslie et al., 2007; Lobov et al., 2007; Siekmann et al., 2007; 
Suchting et al., 2007). Hence, endothelial cells experiencing the highest level of VEGF 
signaling will be selected as tip cells. Notch activation in stalk cells suppresses 
VEGFR2 and VEGFR3/FLT4 signaling and proangiogenic fate (Siekmann et al., 2007; 
Tammela et al., 2008). In zebrafish, flt4 is normally expressed in tip cells. Loss of 
Notch signaling results in an expansion of flt4 expression throughout the stalk cell 
domain and in an increase of endothelial cells showing tip cell behaviours, including the 
hyper-sprouting phenotype.  
Besides a direct regulation of VEGF signaling, the DLL4-Notch pathway may 
indirectly influence local guidance of sprouting vessels. It has been shown that Notch 
Introduction Figure 9 
Delta-Notch signaling in tip/stalk cell specification (modified after Suchting 
et al., 2009) 
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signaling can positively regulate FLT1 expression (Funahashi et al., 2010). FLT1 in 
stalk cells act as decoy receptor for VEGFA to further prevent VEGFA-mediated tip 
cell specification. Hence, knock-down of flt1 in zebrafish promotes increased tip cell 
formation (Krueger et al., 2011). Tip cell specification is also promoted by the stalk 
cell-restricted expression of Jagged 1, another Notch ligand (Benedito et al., 2009). 
Glycosylation of Notch receptors by Fringe family glycosyltransferases enhances Notch 
signaling via DLL4 but represses signaling via Jagged 1. Stalk cell-restricted Jagged 1 
competes with DLL4 for Notch binding and suppresses Notch signaling in tip cells. 
Thus, endothelial-specific Jagged1 knock-out mice exhibit retinal vessels with disrupted 
tip cell formation and vascular sprouting, whereas tip cell formation is enhanced upon 
endothelial Jagged 1 gain-of-function. 
	  
1.2.3.2 Integrin signaling in angiogenesis 
	  
Communication between endothelial cells and their environment plays an important 
role in angiogenesis and cancer progression, Thereby angiogenesis is regulated by 
integrins. Integrins belong to a family of receptors for ECM proteins and 
immunoglobulin superfamily molecules. They form heterodimers of non-covalent 
single-pass type I transmembrane α and β subunits (Humphries et al., 2006; Hynes et 
al., 2002). Integrins can bind to ECM proteins or receptors of adjacent cells with their 
extracellular domain to mediate cell adhesion and binding their cytoplamic tails to the 
intracellular cytoskeleton (Calderwood et al., 2000; Evans et al., 2007). Besides cell 
adhesion, integrins mediate outside-in or inside-out signaling. These signals determine 
cellular responses such as migration, survival, motility, and differentiation (Calderwood 
et al., 2004; Hynes et al., 2002; Miranti et al., 2002). Integrin activation requires 
conformational changes of the heterodimer (Introduction Fig. 10) and can be modulated 
by the expression of different integrin genes or by growth factor or chemokine receptor 
signaling. Integrin signaling can be activated by binding of different intracellular 
proteins including talin and kindlin. Binding of the PTB domain of talin to the 
conserved WxxxNP(I/L)Y motif of the β integrin cytoplasmic tail results in integrin 
activation (Wegener et al., 2007). Talin also binds to the actin cytoskeleton and various 
signaling proteins, thereby directly connecting activated integrins with the cytoskeletal 
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network (Critchley et al., 2008). In addition, it has been shown that proteins of the 
kindlin family can bind to the integrin NPxY motif via their FERM domain, and 
inhibition of talin suppresses integrin activation (Kloeker et al., 2004; Ma et al., 2008; 
Montanez et al., 2008; Moser et al., 2008). Activated integrins then assemble a 
multiprotein complex at their cytoplasmic tail, which includes focal adhesion kinase 
(FAK), Src-family kinases, integrin-linked kinase, vinculin, or paxilin and is 
responsible for outside-in signaling (Deakin et al., 2008; Giannone et al., 2006; 
Ginsberg et al., 2005; Legate et al., 2006; Mitra et al., 2005; Ziegler et al., 2006).  
The role of αvβ3 in angiogenesis suggests that some pathological conditions might 
depend on αvβ3 signaling. Expression analyses of cerebral cavernous malformations 
(CCM) from human brain tissue revealed that αvβ3 is strongly expressed in CCM 
endothelium (Seker et al., 2006). Knock-out of β3 integrin in mice leads to embryonic 
lethality of 50% due to intrauterine bleeding or defective placental development 
(Hodivala-Dilke et al., 1999). Intriguingly, only postnatal mice lacking β3 integrin 
exhibit coronary capillaries of irregular endothelial thickness, with endothelial 
protrusions into the lumen, and expanded cytoplasmic vacuoles caused by enhanced 
Introduction Figure 10 
Integrin activation by outside-in or inside-out signaling (adapted from Shattil et al., 2010) 
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VEGF signaling (Weis et al., 2007). Further studies in mice suggested that integrins of 
glial cell play an important role in maintaining the blood-brain barrier, since neuronal-
specific integrin αv knock-out mice exhibit enlarged, disrupted blood vessels, with 
defective apposition of endothelial or glial cells (McCarty et al., 2002). 
Besides β3 integrin signaling, fibronectin-mediated β1 integrin activation has a 
crucial role in vascular development. Fibronectin, a component of the ECM, is 
produced and secreted by endothelial cells during normal and tumor angiogenesis 
(Clark et al., 1982; Kim et al., 2000; Liao et al., 2002). Endothelial-specific deletion of 
β1 integrin in mice leads to severe vascular defects. Furthermore, endothelial cell 
proliferation and vessels branching is impaired, arguing for a essential role of β1 
integrin in angiogenesis (Bloch et al., 1997). Integrin α5β1 is poorly expressed by 
quiecent endothelial cells, but is up-regulated during tumor angiogenesis (Kim et al., 
2000); their expression is regulated by the homeobox family transcription factor 
HOXD3 (Boudreau et al., 2004). 
Integrin α4β1 is expressed on neovessels of tumors in response to VEGF, IL1β, 
bFGF, and TNFα signaling . Binding of VCAM1, expressed by smooth muscle cells 
(VSMCs), to endothelial cells promote adhesion between these two cell types. Loss of 
integrin α4β1 causes cell death of both endothelial cells and pericytes (Garmy-Susini et 
al., 2005). 
 
1.2.3.3 The role of EGFL7 in vascular development 
 
Epidermal growth factor-like domain 7 (EGFL7) is a secreted angiogenic signaling 
molecule, predominantly expressed by endothelial cells (Fitch et al., 2004). It consists 
of a N-terminal signal peptide domain, an EMI-like domain, and two centrally located 
EGF-like domains. During embryogenesis and pathological angiogenesis Egfl7 is 
mostly expressed by proliferating endothelial cells (Campagnolo et al., 2005; Fitch et 
al., 2004; Parker et al., 2004; Soncin et al., 2003). In the developing retinal vascular 
plexus, Egfl7 expression is restricted to sprouting vessels with a basal localization in 
stalk cells and a patchy expression in tip cells (Schmidt et al., 2007). EGFL7-depleted 
cultured human umbilical vein endothelial cells (HUVECs) fail to proliferate. 
Additionaly, depletion of EGFL7 supresses endothelial cell migration and inhibits 
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capillary sprouting (Nichol et al., 2010). It has been suggested that EGFL7 promotes 
these processes by modulating ECM rigidity. EGFL7 inhibits the deposition of mature 
elastic fibers by repressing lysil oxidase (LOX)-mediated conversion of tropoelastin 
into elastin (Lelievre et al., 2008). 
In vivo studies in zebrafish demonstrated that knock-down of Egfl7 causes 
pericardial edema, hemorrhaging, and circulatory loop defects due to impaired 
tubulogenesis of the developing vessels. Furthermore, endothelial cell membranes 
exhibit disrupted tight, adherens and gap junctions (De Maziere et al., 2008; Parker et 
al., 2004). The study of the role of Egfl7 in vascular development has been complicated 
by the presence of the pro-angiogenic microRNA miR-126 within the EGFL7 gene 
(Kuhnert et al., 2008; Nicoli et al., 2010; Wang et al., 2008). Egfl7 loss-of-function 
mouse models exhibit partial embryonic lethality and vascular abnormalities (Schmidt 
et al., 2007). Later experiments showed that these vascular defects can be attributed to a 
loss of miR-126 rather than a loss-of-function of Egfl7 (Kuhnert et al., 2008). In 
addition, endothelial-specific miR-126 knock-out mice exhibit vascular defects similar 
to those of Egfl7 loss-of-function mice (Kuhnert et al., 2008; Wang et al., 2008). 
Overexpression of Egfl7 in murine endothelial cells without affecting miR-126 levels 
resulted in a decrease in cranial blood vessels, collapsed arterial vessels, and abnormal 
endothelial cell aggregates (Nichol et al., 2010). These phenotypes are mediated, at least 
in part, by modulation of Notch signaling: EGFL7, as an endothelial secreted ECM 
protein may interact with Notch receptors in a paracrine or autocrine manner. Depletion 
of EGFL7 in HUVECs inhibited endothelial cell proliferation, sprout formation, and 
migration (Nichol et al., 2010), which could be also obeserved upon Notch signaling 
activation (Henderson et al., 2001; Noseda et al., 2004; Sainson et al., 2005; Taylor et 
al., 2002). It has also been shown that EGFL7 interacts with the Notch receptors Notch1 
and Notch4 and with their ligand, DLL4 (Introduction Fig. 11A) (Nichol et al., 2010; 
Schmidt et al., 2009). Thus, EGFL7 could modulate Notch signaling by binding to the 
Notch receptors or its ligands. Studies in HUVECs suggested that, in contrast to the 
postnatal retina, EGFL7 enhances Notch signaling in the presence of DLL4 during 
embryogenesis (Introduction Fig. 11B). This finding is suggested to involve the binding 
of EGFL7 to Jagged1, an antagonist of Notch signaling. Then, EGFL7-Jagged1 binding 
Introduction 
33 
prevents the interaction between the Notch receptor and Jagged1, and in turn promotes 
DLL4/Notch signaling activation.	   
The findings that EGFL7 is strongly expressed in several tumors and cancer cell 
lines (Diaz et al., 2008; Huang et al., 2010; Wu et al., 2009), and its possible role in 
tumor angiogenesis make EGFL7 a potential target for antiangiogenesis therapy.  
 
1.3 The transcription factor KLF2 in cardiovascular development 
 
Blood flow and shear stress have an impact on endothelial cytoskeleton remodeling and 
therefore influence their cell morphology (Davies et al., 1997; Kim et al., 1989). The 
Introduction Figure 11 
Regulation of Notch signaling by EGFL7 during (A) postnatal and (B) embryonic 
development. (A) ln the postnatal retina, EGFL7 antagonizes Notch/ligand interaction and inhibits 
target gene expression. (B) During embryonic development, EGFL7 indirectly enhances 
DLL4/Notch signaling by binding to the Notch antagonist Jagged1. ECD: extracellular domain of 
Notch, NICD: intracellular domain of Notch. (adapted from Nichol et al., 2012) 
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transduction of physical forces between the endothelium and the surrounding tissue is 
important for maintaining vascular homeostasis and function. Mechanical forces exerted 
by blood flow act on the apical surface of endothelial cells and are translated into 
molecular signals for vascular function. These forces can act parallel to the direction of 
flow and result in shear stress, or perpendicular to the vessel wall and tensile stress 
(White et al., 2007). Accordingly, different downstream signaling cascades may be 
activated and regulate endothelial cell behaviour and morphology. One of the best 
characterized genes is the zinc-finger transcription factor KLF2. The zebrafish genome 
habours two KLF2 paralogues, klf2a and klf2b due to genome duplication. Zebrafish 
Klf2a is considered to be the ortholog of the human and murine KLF2. In adult human 
tissue samples, KLF2 mRNA was detected in the heart, skeletal muscle, pancreas, 
lungs, placenta, and vascular tissues (Wani et al., 1999). In the vasculature, KLF2 
expression levels within the endothelium correlates with local shear stress patterns 
(Introduction Fig. 12). Decreased KLF2 expression is generally seen in areas of lower 
shear stress levels and disturbed flow patterns (Dekker et al., 2002; Dekker et al., 2005; 
Parmar et al., 2006). In HUVECs, it has been demonstrated that KLF2 overexpression 
results in stretched shaped endothelial cells with actin stress fiber formation even in the 
absence of blood flow. In contrast, the shear stress induced alignment of endothelial 
cells in flow direction is abolished after siRNA-mediated KLF2 silencing (Boon et al., 
2010). Further studies demonstrated that KLF2 is not only expressed in large blood 
vessels, but also in the duodenal, hepatic, or the glomerular microvasculature (Gracia-
Sancho et al., 2011; Kobus et al., 2012; Slater et al., 2012).  
In zebrafish, klf2 expression starts at 70% epiboly in the ventral, animal portion of 
the epiblast (Oates et al., 2001). At 24 hours post fertilisation (hpf), klf2a is expressed in 
head vessels, the heart, clusters of cells lateral to the most posterior notochord, and in 
the anus. At 36 hpf klf2 mRNA expression can be detected in the trunk vasculature, and 
after two days in endocardial cells of the developing heart valves. Concomitant with 
human and mice, klf2 expression in the zebrafish vasculature is blood flow dependent 
(Parmar et al., 2006; Stainier et al., 1996; Wang et al., 2011).  
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Shear stress-induced expression of KLF2 requires a single consensus myocyte 
enhancer factor 2 (MEF2)-binding site up-stream of the transcription start of the Klf2 
gene (Introduction Fig. 12) (Kumar et al., 2005). Phosphorylation of MEF2 by the 
MEK5/ERK5 pathway is critical for the expression of KLF2 under shear stress (Parmar 
et al., 2006; Young et al., 2009). Epigenetic modification of MEF2 is another 
mechanism for the regulation of KLF2 expression. Under low blood flow conditions, 
histone deacetylase 5 (HDAC5) binds to MEF2 and inhibits its transcriptional activity. 
Phosphorylation of HDAC5 in a Ca2+/ calmodulin-dependent manner under high 
laminar shear stress results in dissociation of HDCA5 from MEF2 and transcription of 
KLF2 (Wang et al., 2010a). Blood-flow dependent expression of KLF2 can be also 
regulated by the endothelial thioredoxin-interacting protein (TXNIP). Under disturbed 
flow conditions TXNIP is up-regulated and binds as a part of a transcriptional repressor 
complex to the shear responsive region of KLF2 promoter and inhibits KLF2 expression 
Introduction Figure 12 
Regulation and function of KLF2 in endothelial cells	  (adapted	  from	  Atkins	  et	  al.,	  2007)	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(Wang et al., 2012). Recent data demonstrated a contribution of microRNAs in blood 
flow-mediated regulation of KLF2: Under laminar flow, miR-92a is down-regulated 
which results in higher levels of KLF2 expression. Overexpression of miR-92a 
decreases KLF2 expression by binding to a miR-92a-binding site at the KLF2 3´-UTR 
region (Bonauer et al., 2009).  
Besides the flow-dependent regulation of KLF2, many drugs have been found to 
induce KLF2 expression independently of flow. One of the best studied group of are 
statins. Statins are inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) 
reductase, a enzyme in cholesterol synthesis and are used in clinical practice. In 
addition, a combination of prolonged shear stress and statins have been shown to have a 
additive effect on KLF2-mediated expression of eNOS and thrombomodulin, because 
shear stress stabilizes KLF2 mRNA via inhibition of PI3K and results in higher KLF2 
mRNA levels (Introduction Fig. 12) (van Thienen et al., 2006). Concomitant with these 
findings, it has been shown that rapamycin increases KLF2 expression in HUVECs by 
inhibition of mTOR, a component of the PI3K/AKT/mTOR pathway (Hay et al., 2004; 
Ma et al., 2012). 
Blood-flow mediated gene expression plays a important role in vascular homeostasis, 
endothelial barrier function, vasodilation, angiogenesis, and inflammation. KLF2 
regulates the expression of about 70% of shear-stress induced endothelial genes 
together with nuclear factor erythroid2-related factor 2 (Nrf2) (Fledderus et al., 2008). 
 
1.3.1 KLF2 in angiogenesis and valvulogenesis 
	  
Several studies have shown that VEGF signaling is a key regulator of physiologic and 
pathologic angiogenesis by promoting EC cell migration, vascular permeabilty, 
inflammation, and endothelial cell survival (Ferrara et al., 2003; Kim et al., 2001; 
Leung et al., 1989; Maharaj et al., 2007; Senger et al., 1983). During zebrafish 
development, blood flow-mediated expression of klf2a has a pro-angiogenic role in 
aortic arch development (Introduction Fig. 13). Klf2a induces the expression of the 
endothelial-specific mircroRNA miR-126 which inhibits spred-1 a negativ regulator of 
VEGF signaling. Loss of klf2a down-regulates miR-126 and inhibits pro-angiogenic 
VEGF signaling by the up-regulation of spred-1 (Nicoli et al., 2010).  
Introduction 
37 
In Xenopus, Klf2 regulates Flk1 expression by binding, together with the ETS 
transcription factor ERG to the enancer of the Flk1 gene. Knock-down of Klf2 leads to 
severe vascular defects due to a significant decrease of Flk1 (Meadows et al., 2009). 
Together, these studies indicate that Klf2 has pro-angiogenic role during embryonic 
development. Conversely, studies in mice demonstrated an opposite effect of Klf2 
overexpression on VEGF-mediated angiogenesis. Moreover, KLF2 competes with Sp1 
for a binding site in the VEGFR2 promoter and overexpression of KLF2 in HUVECs 
inhibits VEGFR2 expression (Bhattacharya et al., 2005). Additionaly, angiogenesis can 
also be induced under hypoxic conditions by the activation of the hypoxic-inducible 
factor 1 (HIF-1). KLF2 knock-down in HUVECs increases the expression of HIF-1 
target genes including VEGF, whereas KLF2 overexpression inhibits their expression 
and also results in a failure endothelial tube formation (Kawanami et al., 2009). 
In adult, endothelial progenitor cells (EPCs) participate in neovascularization 
(Asahara et al., 1997). EPCs are bone marrow-derived cells and circulate in the blood 
stream. Recent studies have shown that KLF2 overexpression in human EPCs increases 
their cell number and improves neovascularization capacity in an ischemic hind limb 
model (Egorova et al., 2012).  
Cardiac valve formation in vertebrates is essential for a functional circulatory 
system. Cardiac cushions at the atrioventricular canal (AVC) are remodeled and become 
functional valves (Armstrong et al., 2004). In zebrafish, it has been shown that klf2a 
plays a major role cardiac valve development. Klf2a expression is up-regulated by 
retrogade flow at the AVC and knock-down of klf2a and its target genes bmp4, notch1b, 
edn1, and nrg1 results in valvular defects (Introduction Fig. 14) (Vermot et al., 2009). 
Studies in murine endothelial cells indicate that shear stress at the AVC activates 
Introduction Figure 13. 
Pathway for blood flow-mediated angiogenesis 
via Klf2a during aortic arch development 




Tgfβ/Alk5 signaling. Then, Alk5 activates the MEK5/ERK5/MEF2 pathway and 
induces Klf2 expression (Egorova et al., 2011). Analyses of the zebrafish mutant bungee 
(bngjh177) revealed the important role of klf2a in valve development. In these mutants, 
the phosphorylation of Hdac5 is impaired. Consequently, Hdac5 remains in its active 
state to the klf2a promoter and inhibits the expression of klf2a which results in cardiac 
valve defects (Just et al., 2011). 
 
1.3.2 KLF2 in vascular tone regulation 
 
Vascular tone is controlled by various factors produced in endothelial cells. Among 
these factors, eNOS, C-natriuretic peptide (CNP), and adrenomodulin act as a 
vasodilator, whereas endothelin-1 (ET1) and angiotensin-converting enzyme (ACE) 
have a vasoconstrictiv function (Chauhan et al., 2003; Drexler et al., 1999; Malek et al., 
1993). KLF2 binds to the eNOS promoter and induces its expression. Moreover, KLF2 
also induces CNP and inhibits ET1 and ACE expression (Dekker et al., 2005; 
SenBanerjee et al., 2004). 
Introdction Figure 14.  
Klf2 function during heart valve formation 
in zebrafish. (adapted from Vermot et al., 
2009) 
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2 Aims of this study 
 
The cerebral cavernous malformation (CCM) protein complex is crucial for normal 
blood vessel development and vascular integrity. Patients with cerebral cavernous 
malformations (CCMs) frequently suffer from hemorrhages and/or cavernoma leading 
to strokes or even death due to a loss of any of the three genes, KRIT1/CCM1, 
CCM2/OSM, or CCM3/PDCD10. However, the roles of CCM proteins during 
cardiovascular development remain largely unknown.  
In this study, microarray expression analyses yield a first hint for potential candidate 
genes. Furthermore, knock-down experiments of candidate genes or pharmacological 
inhibition of different signaling pathways shed light on the molecular relationships 
between the CCM complex proteins and vascular signaling cascades during zebrafish 
embryonic cardiovascular development. 
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3 Material and Methods 
 
3.1 In vivo experiments 
 
3.1.1 Fish maintenance and stocks 
 
Zebrafish embryos were kept in egg water (60µg/ml Instant Ocean Sea Salts, Aquarium 
Systems Inc., USA; 1µg/ml Methylene blue) at 28,5°C. To prevent pigmentation, 
embryos were kept in egg water supplied with 0,003% (w/v) PTU (1-Phenyl-2-thiourea, 
Sigma-Aldrich, USA). Embryos were staged according to morphological criterias 
(Kimmel et al., 1995). Adult zebrafish were maintained under standard conditions at 
28,5°C (Westerfield et al., 1997). 
The following fish lines were used: 
 
Transgenic lines: 
Tg(myl7:GFP)twu34 (Huang et al., 2003) 
Tg(kdrl:GFP)s843 (Jin et al., 2005) 
 
Mutant lines: 
hegm552 (Mably et al., 2003) 
krit1ty219c (Mably et al., 2006) 
ccm2m201 (Mably et al., 2006) 
tnnt2ab109 (Chen et al., 1996) 
 
 
3.1.2 Embryo injections 
 
Glass injection needles (Drummond Scientific, USA) were pulled in a P-97 
Flaming/Brown Micropipette puller Sutten Instruments). For injections, needles were 
fixed onto a micromanipulator (MM33 Micromanipulator, Maerzhaeuser, Germany) 
and connected to a microinjector (MPPI-2 Pressure Injector, BP15 back pressure unit, 
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Applied Scientific Instrumentation). Embryos were injected the stereomicroscope at 1-
cell stage. 
 
3.1.3 Morpholino and expression construct injections 
 
Morpholino antisense oligonucleotides were purchased from GeneTools, LLC, USA. 
Morpholinos (MO)s were diluted with ddH2O to 1mM stock solution and stored at -
20°C. For experiments, MOs were further diluted in Danieau´s. Morpholinos were 
injected into one-cell stage embryos in the following amounts: 
 




(Nicoli et al., 2010) 
5‘-GGACCTGTCCAGTTCATCCTTCCAC-3‘ 12ng 
klf2b ATG 
(Renz et al., 2015) 
5‘-AAAGGCAAGGTAAAGCCATGTCCAC-3‘ 12ng 
 5ng klf2aMO + 5ng klf2bMO  
egfl7 ATG 
(Parker et al., 2004) 
5‘-CAGGTGTGTCTGACAGCAGAAAGAG-3‘ 650pg 
 2,5ng klf2aMO + 2,5ng klf2bMO + 0,3ng egfl7MO  
tnnt2a ATG 
(Sehnert et al., 2002) 5‘-CATGTTTGCTCTGATCTGACACGCA-3‘ 
2ng 
itgb1b splice 
(Ablooglu et al., 
2010) 
5‘-GCCAGTTTGAGTGAATAACTCACCT-3‘ 6,3ng 
icap-1 ATG 5‘-TCGAAACATCCTTCACCATGACGCC-3‘ 8,3ng 
	  
The plasmids hsp70l:klf2a_IRES_GFP or hsp70l:klf2b_IRES_GFP (Renz et al., 2015) 
were injected into one-cell stage embryos together with the tol2 transposase capped 
mRNA synthetized using the SP6 polymerase (mMessage Machine, Ambion, USA). 
For efficient genomic integration, a concentration of 12,5ng/µl plasmid DNA and 
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25ng/µl mRNA (diluted in Danieau´s) was used. Injected embryos were raised under 
standard conditions (see fish maintainance and stocks). Based on their strong EGFP 
expression, 1 transgenic fishline Tg(hsp70l:KLF2a_IRES_EGFP)md8 and 2 transgenic 
fishlines Tg(hsp70l:KLF2b_IRES_EGFP)md9,11 were further analyzed. 
 
3.1.4 Heat-shock experiments 
 
Prior to the heat-shock, up to 50 embryos were collected in 50ml tubes and pre-heated 
egg water was added. The heat-shock was performed at 37°C in a waterbath for 40 
minutes. Time-points for the following experiments are detailed within the results 
section. 
 
3.1.5 Pharmacological treatment 
 
Dechorionated embryos were kept in E3 medium and treated with 12,5µM PTK787 
(ChemieTek, USA, Lot# VT-ETJN-2A), a Vegf inhibitor at 28,5°C (Renz et al., 2015). 
Control embryos were treated with 0.01% DMSO (Dimethylsulfoxide, Sigma-Aldrich), 
at 28,5°C. Briefly, embryos were treated in a 1% agar-coated petridish to prevent 
sticking to it. After treatment, embryos were washed several times with E3 medium and 
then transferred to a new petridish. Treatment protocols for the different experiments 
are detailed within the results section. 
 
3.1.6 Embedding of embryos for live imaging 
 
Embryos were anesthetised with 0,03% Tricaine (3-amino benzoic acid ethylester, 
Sigma-Aldrich, USA) in E3 medium for 2 minutes and then embedded in 1% Low 
Melting Agarose (Lonza, Switzerland, cat# 50081)/0,03% tricaine solution on a 
Petridish. Embryos were covered with 0,03% tricaine solution to prevent dehydration of 
the agarose during imaging. Multiple z-stacks were recorded at the Zeiss confocal 
microscope LSM700 with 20x/dry objective. Between each timepoint, embryos were 
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removed from the agarose and incubated in petridishes in E3 medium without Tricaine 
at 28,5°C.  
 
3.2 Molecular biology methods 
 
3.2.1 Total RNA extraction and cDNA synthesis 
 
20-30 live embryos were collected in a 2ml Eppendorf tube (Eppendorf, Germany) and 
1ml Trizol (Invitrogen, USA, cat#15596-026) was added. Total RNA was extracted 
according to manufacturer´s protocol. The RNA pellet was dissolved in 25µl RNAse-
free ddH2O. 
cDNA was generated from total RNA by using the Sensiscript Reverse Transcription 
Kit (Qiagen, Germany, cat#205211) according manufacturer´s protocols. 
 
3.2.2 In vitro transcription of DIG-labelled antisense RNA 
 
The templates for the in situ hybridization probes for klf2a and klf2b were generated by 
PCR amplification using 24hpf WT cDNA. The amplicons were cloned into the pSC-B 
vector with the StrataClone Blunt PCR Cloning Kit (Stratagene, cat#240207). Antisense 
RNA was generated by in vitro transcription using the DIG RNA Labeling Kit (Roche 
Diagnostics, Zwitzerland, cat#11175025910) in collaboration with Jana Richter. 
 
PCR-Primer : 
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3.2.3 Extraction of cardiac tissue 
 
Whole hearts were extracted manually with collaborative support of Franziska Rudolph 
(MDC, Berlin) and Jana Richter (MDC, Berlin) (Lombardo et al., 2015). For heart 
extraction, a modified protocol after Burns (Burns et al. 2006) was used. 50-100 of 
wild-type or ccm2m201 mutant embryos in the transgenic line Tg(myl7:GFP)twu34 
background were collected in a 1,5 ml Eppendorf tube and washed twice with 10% fetal 
bovine serum (FBS, Sigma-Aldrich, USA) in L-15 (Gibco, cat#11415-049). Embryos 
were ruptured by repeated uptake into a loading pipette and filtered on a 100µM nylon 
mesh (BD Bioscience, cat#BD352360). Subsequently the flow-through was filtered 
again on a 30µM mesh (Miltenyi Biotec., cat#130-098-458) which retained the hearts. 
Hearts were then washed out onto an agar-coated plate containing 10%FBS/L-15, 
collected under a stereomicroscope (Leica MZFLIII) and transferred into RNAlater 
(Ambion, USA, cat#AM7020) for RNA stabilization. This procedure was repeated 
several times to obtain sufficient heart tissue for RNA extraction. 
 
3.2.4 RNA extraction and processing 
 
Total RNA was extracted with the RNeasy Micro Kit (Qiagen, Germany, cat#74004). 
RNA was quantified on a ND-1000 spectrophotometer (Nanodrop Technologies). For 
quality analysis, the 2100 Bioanalyzer RNA 6000 Nano chip (Agilent Technologies) 
was used. RNA processing and chip hybridization was done by imaGenes GmbH 
(Berlin, Germany). Briefly, for each sample, 200ng of intact (RIN>8) total RNA was 
subjected to a single amplification step and Cy3 labeling reaction. 1,5 mg of labeled 
cRNA were hybridized to Zebrafish (V2) Gene Expression Microarrays (G2519F-
019161, 4x44K) and spot intensities recorded on a G2565BA scanner (Agilent 
Technologies). Microarrays were performed in duplicates for WT and CCM2 samples. 
Raw expression values were adjusted in R (www.r-project.org) using variance stability 
normalization (Huber et al., 2002). Significance p-values for differentially expressed 
probes were calculated with the limma R package (G Smyth 2005) and associated false 
discovery tresholds determined according to the Benjamini and Hochberg FDR method 
(Benjamini et al., 1995). 
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3.2.5 Gateway cloning  
 
The open reading frame of zebrafish klf2a (NM_131856, (Vermot et al., 2009) was 
amplified by PCR using the Phusion polymerase (Finnzymes, Finland) and cloned via 
BP Gateway (Kwan et al., 2007 ; Villefranc et al., 2002) recombination into the 
pDONR 221 vector (Invitrogen, USA) to generate a middle entry vector referred to as 
pME-klf2a. To generate an injection construct, a LR Gateway recombination reaction 
with pDestTol2, p5E-hsp70l, pME-klf2a and p3E-IRES_EGFP was performed to 
generate pTol2-hsp70l:KLF2a_IRES_EGFP. Similarly, the open reading frame of 
zebrafish klf2b (NM_131857) was amplified and cloned via BP Gateway (Kwan et al., 
2007; Villefranc et al., 2007) recombination with pDONR 221 to generate the middle 
entry vector pME-klf2b. To generate an injection construct, a LR Gateway 
recombination reaction with pDestTol2, p5E-hsp70l, pME-klf2b and p3E-IRES_EGFP 
was performed to generate pTol2-hsp70l:KLF2b_IRES_EGFP. All Gateway plasmids 
were kindly provided by Nathan Lawson´s and Shu Chien´s lab. 
 










3.2.6 Quantitative RT-qPCR 
The RT-qPCR was performed in collaboration with Dr. Cécile Otten (MDC, Berlin) as 
described (Renz et al., 2015) using 6ng total cDNA. Quantitative real-time PCR was 
performed with iTaqTM Universal SYBR Green Supermix (Bio-Rad) in a 20 µl 
reaction on a ABI Prism 7900 sequence detection system (Applied Biosystems). 
Product sizes were controlled by DNA gel electrophoresis and the melt curves were 
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evaluated using the SDS 2.4 software (Applied Biosystems). Ct-values were determined 






Embryos were fixed in 4% paraformaldehyde (PFA) in PBS (see 3.7) for 1 hr at RT on 
a shaker. Embryos were then washed four times in PBT for 5 min each at RT and 
subsequently 5 min in ddH2O. Then embryos were briefly rinsed in PBDT. Embryos 
were incubated at least 2hrs at RT in PBDT/5% NGS (normal goat serum, Invitrogen, 
USA) solution for blocking. Embryos were incubated with the primary antibody 
Zn8/Alcam (1:100 Developmental Studies Hybridoma Bank) with PBDT/1%NGS 
overnight at 4°C on a shaker. Next, embryos were extensively washed several times 
with PBDT/1% NGS for at least 3 hrs and incubated with the secondary antibody Cy5-
conjucated goat-anti-mouse (1:250; Jackson ImmunoResearch Laboratories, 
cat#968229) in PBDT/1%NGS overnight at 4°C. For actin staining, Rhodamine 
Phalloidine (1:100; Sigma-Aldrich, USA, cat#658740) was added together with the 
secondary antibody. After overnight incubation, embryos were washed several times  
extensively with PBDT/1% NGS for a total of 3hrs and then embedded for confocal 
imaging.  







Dr.29173 Klf2aDr_rev 5‘-CCAGTATAAACTCCAGATCCAGG-3‘ 
Klf2bDr_fwd 5‘-GGATAGATGGAAGATTGAGGAGCA-3‘ Dr.9976 
Klf2bDr_rev 5‘-CTCCAGGTCTAAATAATTGCTGAG-3‘ 
Egfl7_fwd 5‘-TTTACCCAGAATGCTGTCCG-3‘ Dr.89996 Egfl7_rev 5‘-AAAACTGCCCAGCGTATTCA-3‘ 
Eif1bDr_fwd 5‘-CAGAACCTCCAGTCCTTTGATC-3‘ Dr.162048 
Eif1bDr_rev 5‘-GCAGGCAAATTTCTTTTTGAAGGC-3‘ 
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3.3.2 Zebrafish embedding 
 
Hearts were dissected from whole embryos under a stereomicroscope (Leica MZFLIII, 
Germany) using forcep and needle, placed into a drop of 6µl Slow Fade Gold antifade 
reagent (Invitrogen, USA, cat#536938) on a slide (superfrost, 76x26mm, Menzel, 
Germany) in a ring of vaseline to prevent damages by the coverslip (18x18mm #1, 
Roth, Germany). For whole mount imaging, the embryos were embedded in 1% Low 
Melting Agarose (Lonza, USA)/ PBS. 
 
3.3.3 Whole mount in situ hybridization 
 
Whole mount in situ hybridizations were performed with the help of Dr. Cécile Otten 
(MDC, Berlin). For the solutions, see 3,7. Embryos were fixed with 4% PFA overnight 
at 4°C, washed several times in 100% methanol and stored at -20°C for dehydration. 
For in situ hybridization, embryos were rehydrated at RT with: 
 
 75% Methanol/ 25% PBT (5 min) 
 50% Methanol/ 50% PBT (5 min) 
 25% Methanol/ 75% PBT (5 min) 
 100% PBT (4x5 min) 
 
Embryos were then permeabilized with Proteinase K (10µg/ml in PBT) for 15 minutes 
at RT and briefly washed in PBDT. After fixation with 4% PFA for 20 minutes, 
embryos were washed 5 times for 5 minutes with PBT. Embryos were incubated for at 
least 2 hrs in prehybridization buffer  at 67°C. After prehybridization embryos were 
incubated overnight at 67°C in 5µg/ml of DIG-labeled RNA probe in pre-heated 
hybridization buffer. After overnight incubation, embryos were washed in different pre-
heated (67°C) solutions: 
 
 Hyb buffer (20 min) 
 50% SSCT (2x)/ 50% Formamide (3x20 min) 
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 75% SSCT (2x)/ 25% Formamide (20 min) 
 SSCT (2x) (2x 20 min) 
 SSCT (0,2x) (4x30 min) 
 PBT (5 min) 
 
Embryos were incubated in blocking solution for at least 2hrs on a shaker at RT, and 
subsequently incubated with 200µl anti-DIG antiserum (1:4000 in PBT + 2mg/ml BSA) 
overnight at 4°C. Embryos were washed several times (6-8 times over 3hrs) with PBT 
on a shaker at RT. Then embryos were washed 3 times (5 min each) in freshly prepared 
NTMT solution. During this step, the embryos were transfered into a 24 well plate. 
Then, embryos were incubated in staining solution at RT. The staining was stopped by 
washing the embryos three times in PBT. Embryos were transferred into 1,5ml 
Eppendorf tubes and cleared with benzyl-benzoate (2:1, Sigma-Aldrich, USA). For 
imaging, embryos were mounted in permount (Fisher Scientific, USA). Stained 
embryos were imaged at the Axioplan2 microscope (Zeiss, Germany) using a SPOT 





3.4.1 Confocal imaging 
	  
Immunostained embryos were scanned at the Zeiss confocal microscope LSM700 with 
20x/dry or 40x/oil objectives. Images were analyzed with the LSM image browser 4.2 
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3.5 Data analysis 
 
3.5.1 Statistical analysis of endocardial and lateral dorsal aorta cell numbers 
	  
In Figure 9, 12 and Figure 16, nuclei were visualized by Tg(kdrl:GFP)s843 expression 
and were counted within the heart (for endocardium), or in both lateral dorsal aortae in 
an area defined between the branching point from the dorsal aorta and the branching 
point of the first aortic arch. Cell numbers are shown as means with S.E.M. Prism 5 
(GraphPad) was used to perform unpaired t-tests and Bonferroni´s multiple comparisons 
test. Means are statistically significantly different when P < 0.05 (for detailed 
information see appendix) 
 
3.5.2 Statistical analysis of the subintestinal vein (SIV) branchpoints and sprouts 
	  
In Figure 13, SIVs were visualized at 72 hpf by Tg(kdrl:GFP)s843 expression and 
branchpoints and sprouts were counted. Branchpoint and sprout numbers are shown as 
means with S.E.M. Prism 5 (GraphPad) was used to perform 1-way ANOVA tests. 
Means are statistically significantly different when P < 0.05 (for detailed information 
see appendix). 
 
3.5.3 RT-qPCR data analyses 
Results were analyzed using the comparative threshold cycle (Ct) method (2–ΔΔCt) to 
compare gene expression levels between samples as previously described (Livak and 
Schmittgen, 2001). As internal reference genes, zebrafish eif1b was used, yielding 
comparable results (Veerkamp et al., 2013). The results of the RT-qPCR experiments 
shown in Figure 24B and 20F,G are representative of more than 3 experiments. The 
mRNA expression levels of klf2a, klf2b, egfl7 (zebrafish) are shown as relative mean 
values with S.E.M. The statistical analysis was done with Prism 5 (GraphPad) using the 
following algorithm: unpaired t-test, 1-way ANOVA tests followed by Sidak´s Multiple 
Comparisons Tests, or 1-way ANOVA tests with Dunnett’s Multiple Comparison Test. 
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 LSM browser 4.2 (Zeiss, Germany) 
 Adobe Photoshop CS5 (Adobe Systems Inc, USA) 
 Adobe Illustrator CS5 (Adobe Systems Inc, USA) 
 Volocity 5.3 (Perkin Elmer, USA) 
 ImageJ 1.48 
 Metamorph (Molecular Devices, USA) 
 MacVector (MacVector Inc, USA) 
 Bookends 12.2.4 (Sonny Software, USA) 
 GraphPadPrism5 





anti-DIG antiserum Anti-Digoxigenin-AP (Roche Diagnostics, Switzerland) 
blocking solution 5% sheep serum (Dianova, Germany), 10mg/ml BSA 
(Sigma-Aldrich, USA) in PBT 
Danieau´s 58mM NaCl; 0,7mM KCl; 0,4mM MgSO4; 0,6mM 
Ca(NO3)2; 5mM HEPES; pH 7,2 
DMSO Dimethylsulfoxide (Sigma-Aldrich, USA) 
E3 medium 5mM NaCl; 0,17mM KCl; 0,33mM CaCl2; 0,33mM MgSO4 
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hybridization buffer 5x SSC (20x); 0,1% Tween; 9mM citric acid; 50% 
formamide; 0,5mg/ml Torula yeast RNA (Sigma-Aldrich, 
USA); 50µg/ml heparin (Sigma-Aldrich, USA); pH 6-6,5 
NTMT 100mM Tris HCl; 50mM MgCl2; 100mM NaCl; 0,1% 
Tween 20; pH9,5 
PBDT PBT; 1% DMSO 
PBS 2,7mM KCl; 80,9mM NaHPO4; 1,5mM KH2PO4 in ddH2O; 
pH 7,4 
PBT PBS; 0,1% Tween (Sigma-Aldrich, USA)  
4% PFA 4% paraformaldehyde in PBS 
pre-hybridization 
buffer 
5x SSC (20x); 0,1% Tween; 9mM citric acid; 50% 
formamide 
Proteinase K 10µg/ml (Roche Diagnostics, Switzerland) in PBT 
SSC (20x) 3M NaCl; 300mM citric acid in ddH2O; pH 7,0 
SSCT (0,2x) SSC (20x); 0,1% Tween in ddH2O, pH 7,0 
SSCT (2x) SSC (20x); 0,1% Tween in ddH2O, pH 7,0 





4.1 Loss of Ccm2 influences endocardial and myocardial 
morphogenesis 
 
Previous studies have shown, that krit1, ccm2, and heg are expressed in endothelial and 
endocardial cells in zebrafish (Kleaveland et al., 2009; Mably et al., 2003; Mably et al., 
2006). The role of Ccm complex proteins in endocardial morphogenesis is largely 
unknown. To analyze the role of Ccm proteins in endocardial development, I used a 
stable transgenic reporter line Tg(kdrl:GFP)s843, which expresses a green fluorescent 
protein (GFP) in endocardial and endothelial cells. In WT embryos, the heart is looped 
and the atrium and the ventricle are connected by the atrioventricular canal (AVC) at 48 
hours post fertilization. In Ccm2-deficient zebrafish, I observed a dilation of cardiac 
chambers, heart looping defects, and an enlargement of the inflow tract region (Fig. 1 
C). To visualize cardiac cushions, I performed an antibody counter staining with an 
Fig. 1 Cardiac cushion phenotype in ccm2m201 mutants.	   (A-D) Shown are hearts of different 
genotypes marked by the endocardial reporter line Tg(kdrl:GFP)s843 (green) and Alcam (red) at 48 
hpf. (B-D) Details showing single confocal z-stacks of the atrioventricular canal (AVC). 
Endocardial cushion cells are marked by Tg(kdrl:GFP)s843 and Alcam (B-D, yellow asterisks) or 
by Alcam alone (B´-D´, inverted image, red asterisks). V, ventricle; A, Atrium; endo, 




anti-ALCAM antibody (Activated Leukocyte Cell Adhesion Molecule), a specific 
marker of the AVC cushions. In WT embryos the cushions consist of compact, cuboidal 
endocardial cells, whereas in ccm2m201 mutants the AVC completely lacks cardiac 
cushions. As previously mentioned, the heart chambers are dilated in ccm2m201 zebrafish 
mutants compared to wild-type embryos. The dilation of cardiac chambers suggested an 
increased endocardial cell number. Cell counts of 2 dpf (days post fertilization) hearts 
showed that in comparison to wild-type embryos (n=3 embryos; average cell 
number=144,7; S.E.M. 1,202) endocardial cell numbers in hegm552 (n=2 embryos; 
average cell number=219,5; S.E.M. 3,5) and ccm2m201 (n=3 embryos; average cell 
number=205,3; S.E.M. 6,692) mutant embryos was massively increased. 
During zebrafish heart development, the myocardial layer grows by addition of new 
cardiomyocytes and in a concentric thickness of the myocardium (Mably et al., 2003; 
Mably et al., 2006). A loss-of-function of Ccm complex proteins has been associated 
with concentric growth defects of the myocardium (Mably et al., 2003; Mably et al., 
2006). Nevertheless, a detailed characterization of cardiac defects in zebrafish ccm 
mutants was missing. To analyze the role of Ccm proteins in myocardial 
morphogenesis, I used an anti-ALCAM antibody, which marks myocardial cell 
membranes. Analyses of myocardial cell shapes showed that the loss of Ccm2 had a 
massive effect on myocardial cell morphology: in particular, ventricular myocardial 
cells were elongated and squamous in ccm2m201 mutant embryos (Fig. 2 B) causing a 
Fig. 2. Cardiac phenotype in ccm2m201 mutants. Comparison of myocardial cell morphology in wild-
type (A) and ccm2m201 mutants (B) at 48 hpf using an anti-ALCAM antibody, which marks myocardial 
cell membranes. V, ventricle; A, Atrium; AVC , atrioventricular canal. 
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thinning of the ventricular chamber (Fig. 3 F), in contrast to WT ventricular myocardial 
cells which are typically cuboidal (Fig. 3D). Furthermore, the dense myofibrilar 




Taken together, my results showed that the loss of Ccm complex proteins has a 
major effect on endocardial and myocardial morphogenesis. Loss of Ccm2 affects 
myocardial cell shapes and prevents cardiac looping. Moreover, the Ccm complex is 







Fig. 3. Loss of Ccm2 causes thinning of the ventricular chamber. (A,B) Myocardial chamber 
organization is visualized by myofibrillar Actin staining in different genotypes at 48 hpf. The dense 
myofibrillar Actin-rich network present in WT is less dense in ccm2m201 mutants. (C-F) Anti-Alcam 
staining indicates that WT ventricular myocardial cells are thicker (D) than in ccm2m201 mutants (F). 




4.2 Endocardial atrioventricular canal markers are misexpressed in 
zebrafish ccm mutants 
 
To elucidate the molecular changes associated with the loss of cardiac cushions in 
zebrafish ccm mutants, a whole mount in situ hybridization (WISH) assay was 
performed. In collaboration with Dr. Cécile Otten, I assessed the expression of genes 
required for the establishment of the atrioventricular canal (AVC), including tbx2b, 
bmp4, and notch1b in ccm mutants. Tbx2b is a myocardially expressed transcription 
factor, which marks the AVC region at 48 hpf (Fig. 4 A). Since it is correctly expressed 
in ccm2m201 mutant hearts (Fig. 4 A), the atrioventricular canal is molecularly defined. 
A molecular signaling cascade, which involves the endocardial gene notch1b and the 
myocardial gene bmp4, triggers cardiac cushion formation (MacGrogan et al., 2011; 
Timmerman et al., 2004). Bmp4 is prominently expressed within the myocardial AVC 
region and the inflow-tract (IFT) (Fig. 4 B). Consistent with the expression of tbx2b, 
bmp4 was correctly expressed in ccm2m201, krit1ty219c, and hegm552 mutant hearts (Fig. 4 
Fig. 4. Expression patterns of atrioventricular canal markers in ccm mutants. Shown are whole 
mount in situ hybridizations in different genotypes at 48 hpf. The AVC region is correctly marked by 
the expression of tbx2b in ccm2m201 mutants (A, A´). (B-E) Expression of bmp4, a myocardial marker 
expressed at the AVC is similar in ccm2m201, hegm552, or krit1ty219c mutants. (B´-E´) Expression of 
notch1b, an endocardial AVC marker, is altered within the entire heart in hegm552, ccm1ty219, and 
ccm2m201 mutants. Arrowheads indicate the AVC. Insets are enlarged views of the AVC region. The 
dotted lines indicate the outline of the heart. AVC, antrioventricular canal 
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C-E). However, contrary to the expression of myocardially expressed genes, I found 
that the expression of endocardial notch1b was impaired in ccm2m201, krit1ty219c, and 
hegm552 mutants (Fig. 4 C`-E`). In contrast to the AVC specific expression in wild-type 
embryos, notch1b was expressed thoughout the entire endocardium in all ccm mutants.  
Several lines of evidence suggest that AVC restricted expression of notch1b is 
crucial for normal cardiac cushion development, since both a loss- and gain-of-function 
of Notch signaling results in defects in AVC formation (Timmerman et al., 2004; 
Watanabe et al., 2006). Vermot et al. demonstrated that notch1b expression at the AVC 
was induced by blood flow. Zebrafish silent heart (tnnt2a) mutants, which lack cardiac 
contractility due to a mutation in the gene encoding cardiac Troponin t2a (Tnnt2a), do 
not express notch1b at the AVC. Furthermore, these mutants also lack cardiac cushions, 
arguing for an impact of blood flow, or of cardiac contraction, in cushion development 
(Chen et al., 1996). Although ccm2m201, krit1ty219c, or hegm552 mutants have heart 
contractions, these mutants lack blood flow within the major blood vessels. To examine 
the role of heart contraction in the misregulation of notch1b, I used a previously 
Fig. 5. Expression patterns of bmp4 and notch1b under no-flow conditions. Shown are whole mount 
in situ hybridizations in different genotypes at 48 hpf. (A-C) Expression of bmp4 at the AVC and the 
IFT in ccm2m201 mutant; tnnt2a morphant, and tnnt2a morphant is similar to WT. (B`) Expression of 
notch1b is abolished in tnnt2a morphants, whereas notch1b is still expressed within the entire 
endocardium in ccm2m201mutant; tnnt2a morphants (C´) compared WT (A´). Arrowheads indicate the 
AVC. Insets are enlarged views of the AVC region. The dotted lines indicate the outline of the heart. 
AVC, antrioventricular canal 
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validated anti-sense oligonucleotide morpholino (MO) against Troponin t2a (Tnnt2a) 
(Sehnert et al., 2002), which prevents cardiac contraction. The bmp4 expression pattern 
was unchanged in tnnt2a morphants (Fig.5 B) and ccm2m201 mutants; tnnt2a morphants 
(Fig.5 C) compared to WT. In contrast, tnnt2a morphants lacked notch1b expression 
within the heart (Fig.5 B´). Intriguingly, in ccm2m201 mutants; tnnta2a morphants, 
notch1b was still broadly expressed within the heart (Fig.5 C´).  
Together, these data demonstrated that the loss of  Ccm proteins prevents cardiac 
cushion formation, although the atrioventricular canal is molecularly defined. 
Furthermore, in contrast to wild-type embryos, the misexpression of notch1b in 
zebrafish ccm mutants is independent of blood flow. 
 
4.3 Loss of Ccm proteins leads to elevated cardiac klf2 expression 
levels 
 
To gain a deeper insight into the molecular changes responsible for cardiac defects in 
ccm2m201 mutants, I performed, in collaboration with Franziska Rudolph and Jana 
Richter, a comparative transcriptome microarray analysis using highly purified cardiac 
tissue from 72 hpf ccm2m201 mutant and WT embryos. Analysis of transcriptional 
changes confirmed that the loss-of-function of Ccm2 affects both endocardial and 
myocardial gene expression, including genes involved in TGFβ signaling, angiogenesis, 
blood vessel development, and cardiac muscle development (data not shown). Since 
Krit1, Ccm2, and Heg are expressed within the endocardium but not the myocardium 
(Kleaveland et al. 2009 Mably et al., 2003; Mably et al., 2006), the altered expression of 
genes with a function in blood vessel development might be a direct consequence, 
whereas changes in myocardial gene expression might be an indirect consequence of the 
loss-of-function of Ccm proteins.  
Among several endocardial genes misregulated in ccm2m201 mutants, the up-
regulation of the zinc-finger transcription factors Klf2a and Klf2b was of particular 
interest. In zebrafish, klf2a plays a crucial role during endocardial cushion formation 
(Vermot et al., 2009). During cushion development, klf2a is induced by pulsatile blood 
flow at the AV boundary and regulates the expression of notch1b, neuregulin1, and 
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endothelin1 (Introduction Figure 14). The role of the klf2b gene during zebrafish 
cardiovascular development has not been elucidated so far. The fact that zebrafish ccm 
mutants lack blood flow, raised the hypothesis that the Ccm complex might regulate 
Klf2 expression within the heart independently of blood flow. 
RT-qPCR for klf2a and klf2b was performed and confirmed the microarray results 
(Fig. 6). Of note, the microarray was done on heart tissue of 72 hpf old embryos, 
whereas the RT-qPCR analyses were done on 48 hpf old whole embryonic tissue. 
Furthermore, whole mount in situ hybridizations showed that klf2a and klf2b mRNA is 
misexpressed in ccm mutants. Endocardial klf2a and klf2b expression is restricted to the 
cardiac cushions at the AVC at 48 hpf in wild-type embryos (Fig. 7 A, A´). In contrast, 
Fig. 6. Klf2 overexpression in ccm2m201 mutants. RT-qPCR 
analyses reveal that loss of Ccm2 causes elevated klf2a/b mRNA 
levels in zebrafish. Statistical data are means and S.E.M.; ns, not 
significant; *, p<0.05; **, p<0.01; ***, p<0.001; ****, p<0.0001. 
(for details see appendix). 
(legend on the next page) 
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both factors are expressed within the entire endocardium in ccm2m201 (Fig. 7 B, B´) and 
krit1ty219c (Fig. 7 C, C´) mutants. 
Taken together, these results showed that the loss of CCM proteins causes an up-
regulation of the blood flow sensitive transcription factor KLF2 in zebrafish hearts.  
 
4.4 Elevated klf2 expression levels induce cardiovascular defects 
similar to the phenotype resulting from loss of Ccm proteins in 
zebrafish 
 
4.4.1 The knock-down of klf2a/b rescues the ccm mutant cardiac phenotype 
 
To functionally test whether the up-regulation of klf2a and klf2b contribute to the 
cardiac phenotype in ccm mutants, I injected anti-sense oligonucleotide morpholinos 
(MOs) into ccm2m201 mutant embryos to partially reduce Klf2a and Klf2b protein levels. 
Since klf2a and klf2b are normally expressed in wild-type zebrafish embryos, a 
complete knock-down of Klf2 might have a phenotype on its own, but a partial 
reduction might restore normal Klf2 protein levels in ccm mutants. To visualize cardiac 
cushion cells, I used an anti-ALCAM antibody. High dose injection of either klf2a 
(12ng) or klf2b (12ng) morpholino only partially rescued endocardial cushion formation 
in ccm2m201 mutants at 48 hpf: The AVC exihibited only few cushion cells in 
ccm2m201mutant; klf2a morphants or in ccm2m201 mutant; klf2b morphants (Fig. 8 E-H). 
Remarkably, a combinatorial injection of only 5ng of each MO could rescue the cardiac 
phenotype in ccm2m201 mutants (no ccm2m201 phenotype among n>100 injected 
embryos; Fig. 8 I, J). The hearts were looped and cardiac cushion cells at the AVC were 
cuboidal, similarly to wild-type hearts. As the cardiac rescue was complete, ccm2m201 
mutant; klf2a/b morphants had to be genotyped to confirm that these were indeed 
ccm2m201 mutant embryos (n=8/16 mutants identified by genotyping). 
Fig. 7. Expression of klf2a and klf2b in ccm mutants. Whole mount in situ hybridization of klf2a 
and klf2b mRNA in different genotypes at 48 hpf. (A, A´) klf2a and klf2b expression is restricted to 
the AVC in WT. (B, B´, C, C´) Both factors are expressed within the entire endocardium in ccm2m201 
and krit1ty219c mutants. V, ventricle; A, atrium; AVC, atrioventricular canal. 
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As ccm2m201 and hegm552 mutants exhibited more endocardial cells than wild-type 
hearts, next I elucidated whether endocardial cell number could be restored when 
Klf2a/b protein levels were decreased in ccm2m201 and hegm552 mutants. Indeed, 
endocardial cell counts showed that endocardial cell numbers in ccm2m201 mutant/ 
klf2a/b morphant embryos were comparable to wild-type embryos (Fig. 9; wt, n=3 
embryos; average cell number=144,7; S.E.M. 1,202; ccm2m201, n=3 embryos; average 
cell number=205,3; S.E.M. 6,692; ccm2m201 mutant/ klf2a/b morphant, n=3 embryos; 
average cell number=131; S.E.M. 2,082).  
Intriguingly, not only the endocardial mutant phenotype was rescued by a reduction 
of Klf2a and Klf2b protein levels, but also myocardial defects. The ventricular actin 
network of ccm2m201 mutant; klf2a/b morphants was more dense than that of ccm2m201 
mutants and morphologically indistinguishable from wild-type. Even the heart looping 
and the dilation of the heart chambers was rescued. Together, these results suggest that 
the myocardial morphogenesis defects in ccm2m201 mutants were caused by an up-
regulation of Klf2 in the endocardium. 
To test whether the knock-down of klf2a and klf2b has a similar effect on cardiac 
morphogenesis of hegm552 and krit1ty219c mutants, I injected klf2a/b morpholinos in these 
mutants. Indeed, knock-down of klf2a/b (5ng of each morpholino) also rescued cardiac 
cushion formation, dilation of the atrial and ventricular chambers, and the myofibrils of 
the ventricular myocardium in hegm552 (n=10/27 mutants identified by genotyping; Fig. 
8 K,L) and krit1ty219c (n=11/32 mutants identified by genotyping; Fig. 8 M,N). 
Together, these results showed that the shear-stress transcription factors Klf2a and 
Klf2b act together downstream of Ccm proteins and that overexpression of both 
contributes to cardiac defects in ccm mutants. 
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4.4.2 Klf2a and Klf2b expression is flow-independent in ccm mutants 
 
Expression of Klf2 is induced by pulsatile shear stress during cardiac cushion formation 
(Chiplunkar et al., 2013; Dekker et al., 2002; Vermot et al., 2009). As zebrafish ccm 
mutants lack blood flow but still have a contractile heart, I was interested whether 
oscillatory flow within the heart chambers is causative for the elevated klf2a and klf2b 
expression levels and the ccm mutant heart phenotype. To asses the role of oscillatory 
flow in the regulation of Klf2 expression, I injected an antisense oligonucleotide 
morpholino (MO) against tnnt2a into ccm2m201 mutant embryos to block heart 
contraction. 
Fig. 8. Rescue of cardiac cushions in ccm2m201, krit1ty219, and hegm552 mutants by knock-down of 
klf2a and klf2b. (A-M) Shown are hearts of different genotypes marked by the endocardial reporter line 
Tg(kdrl:GFP)s843 (green) and Alcam (red) or Actin staining alone (A´-M´) at 48 hpf. Details showing 
single confocal z-stacks of the atrioventricular canal (AVC). Endocardial cushion cells are marked by 
Tg(kdrl:GFP)s843 and Alcam (B-N, yellow asterisks) or by Alcam alone (B´-N´, inverted image, red 
asterisks). (E-H) Neither knock-down of klf2a (E-F) nor of klf2b (G-H) rescues cardiac morphogenesis 
and results in few cardiac cushion cells in ccm2m201 mutants. Double knock-down of klf2a/b recovers 
cardiac chamber differentiation and cardiac cushion formation in ccm2m201, krit1ty219, and hegm552 mutants 
(I-N). V, ventricle; A, Atrium; endo, endocardium; myo, myocardium. Scale bars, 25µm. 
Fig. 9. Increased endocardial cell number in ccm2m201 
mutants. Knock-down of klf2a/b in ccm2m201 mutants rescues 
endocardial cell number.	  Statistical data are means and S.E.M. ns, 




Whole mount in situ hybridization against klf2a/b mRNA showed that klf2a and 
klf2b are expressed at the AVC in wild-type embryos at 48 hpf (Fig. 10 A, A´), whereas 
a lack of blood flow in tnnt2a morphants abolishes the expression of both genes (Fig. 10 
C, C´). Contrary, in ccm2m201 mutants which lack heart contraction and blood flow, 
klf2a and klf2b were misexpressed within the entire endocardium (Fig. 10 D, D). RT-
qPCR on whole embryonic tissue was performed and support the finding that Klf2 
expression levels are still elevated in ccm2m201 mutant; tnnt2a morphants (Fig. 10 E).  
 
  
Fig. 10. Klf2 expression is independent of blood flow in the heart of ccm2m201 mutants. (A-D) Whole 
mount in situ hybridization against klf2a/b mRNA in different genotypes at 48 hpf. Loss of heart 
contraction abolishes klf2 expression at the AVC in tnnt2a morphants (C-C´). (D-D´) Klf2a and klf2b are 
misexpressed within the entire endocardium in ccm2m201mutant; tnnt2a morphants. (E) RT-qPCR 
demonstrates flow-independent overexpression of klf2a/b mRNA in whole embryos. V, ventricle; A, 
atrium; AVC, atrioventricular canal. Statistical data are means and S.E.M.; ns, not significant; *, p<0.05; 
**, p<0.01; ***, p<0.001; ****, p<0.0001. (for details see appendix). 
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Taken together, these results indicated a previously unappreciated role of Ccm 
proteins in cardiac development in limiting the expression levels of the transcription 
factors Klf2a and Klf2b in a flow-independent manner.  
 
4.4.3 Vascular defects are due to increased Klf2 expression in ccm mutants 
 
So far, I could show that the loss-of function of Ccm proteins in the endocardium cause 
an up-regulation of the transcription factor Klf2. This raised the question of whether 
Klf2 expression is also affected in endothelial cells in ccm mutants. Whole mount in 
situ hybridization analyses showed that klf2a is expressed in endothelial cells, e.g. the 
intersomitic vessels (red arrowheads) and the vascular plexus (red arrow) in wild-type 
embryos (Fig. 11 A). In contrast, in ccm2m201 mutants klf2a was up-regulated in most 
endothelial cells including the caudal artery (CA, black arrowhead) and the posterior 
cardinal vein (PCV, white arrowhead) (Fig. 11 B). Since klf2a was strongly up-
regulated within veins and arteries in zebrafish ccm2m201 mutants, I investigated whether 
the up-regulation of Klf2 affects different blood vessels in addition to the endocardium 
and directly causes the ccm mutant phenotype. 
 
Using the stable transgenic reporter line Tg(kdrl:GFP)s843, I could observe an expansion 
of the lateral dorsal aorta (LDA) in ccm2m201 mutants (Fig. 12 B). Endothelial cells 
counts showed, that similar to endocardium, the expansion of the LDA is due to an 
Fig.11 Loss of Ccm2 increases klf2a expression in the vasculature. (A, B) Whole mount in situ 
hybridization for klf2a in different genotypes at 48 hpf. (A) Expression of klf2a in endothelial cells 
(intersomitic vessels, red arrowheads; vascular plexus, red arrow) (B) Elevated klf2a mRNA levels 
within most endothelial cells upon loss of Ccm2 (caudal artery, black arrowhead; posterior cardinal 
vein, white arrowhead).  
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increase in endothelial cell numbers (wt; n=3 embryos; average cell number=57,6; 
S.E.M. 1,45; ccm2m201, n=3 embryos; average cell number=83; S.E.M 1,53). In addition 
to the lateral dorsal aorta, the subintestinal vein (SIV, Fig. 13, arrowhead) of ccm2m201 
mutants exhibit increased numbers of sprouts compared to wild-type (wt, n=10 
embryos; average number of sprouts=0,6; S.E.M. 0,339; ccm2m201, n=10 embryos; 
average number of sprouts=7,3; S.E.M. 0,495) and vessel branch points (wt, n=10 
embryos; average number of branchpoints=9,6; S.E.M. 0,371; ccm2m201, n=10 embryos; 
average number of branchpoints=12,3; S.E.M. 0.882) at 72 hpf (Fig. 13 B, D). Vascular 
oversprouting and branchpoint defects are both hallmarks for increased angiogenesis 
(Ghajar et al. 2013, Yu et al., 2010; Avraham-Davidi et al., 2011). To asses whether 
these phenotypes were due to the up-regulation of klf2a/b, I injected a combination of 
klf2a/b MOs (5ng of each morpholino) into ccm2m201 mutants. Knock-down of klf2a/b 
rescued the endothelial cell number and the dilation defects of the LDA (Fig. 12 C, D; 
n=2 embryos; average cell number=56,5; S.E.M. 3,5). Furthermore, knock-down of 
klf2a and klf2b also restored the sprouting- and branchpoint defects of the SIV (n=5 
embryos; average number of branchpoints=8,2; S.E.M. 0,583; average number of 
sprouts=2,6; S.E.M. 0,678) (Fig. 13 C, D). 
For functional studies, I generated a Tg(hsp70l:klf2a)md8 transgenic zebrafish line for 
heat-shock-inducible klf2a overexpression in the entire embryo. Consecutive heat-shock 
Fig. 12. Elevated klf2 mRNA levels 
causes expansion and increased cell 
number of the lateral dorsal aorta. (A-C) 
Dorsal views of the lateral dorsal aorta 
(LDA, red arrowheads) in different 
genotypes marked by Tg(kdrl:GFP)s843 at 
48 hpf. (B) Expansion and overproliferation 
in ccm2m201 mutants is rescued by knock-
down of klf2a/b mRNA levels (C-D). LDA, 
lateral dorsal aorta; red star, branchpoint of 
the LDA; Statistical data are means and 
S.E.M. ns, not significant; **, p<0.01; ***, 
p<0.001; ****, p<0.0001. (for details see 
appendix). Scale bars, 25µm. 
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induction of this transgene at 15, 30, and again 38 hpf resulted in increased LDA cell 
numbers at 48 hpf  (hsp70l:klf2a; n=2 embryos; average cell number=88,8; S.E.M. 4,5), 
which is comparable to ccm2m201 mutants (Fig. 12 D). 
Together, these results supported the role of Klf2 as a pro-angiogenic factor in 
endothelial cells. 
  
4.4.4 Lack of blood flow mediates cerebral vascular sprout growth in ccm 
mutants 
 
Vascular malformations in iCCM2 knockout mice and in human patients occur 
predominantly in the cerebral vasculature (Boulday et al., 2009; Boulday et al., 2011). 
Therefore, I was particurlarly interested, whether these vessels were also affected in 
ccm mutant zebrafish embryos. Here, I describe for the first time the consequences of 
loss-of-function of the Ccm complex proteins on cerebral blood vessel development in 
zebrafish. The cerebral blood vessel are dilated and well perfused under normal 
conditions. Furthermore, endothelial cells exhibit a smooth surface in wild-type 
embryos (Fig. 14A´). In contrast, within the cerebral vasculature of ccm2m201, krit1ty219c, 
and hegm552 mutants, several blood vessels including the middle and the posterior 
mesencephalic central arteries (pmCtA) are characterized by ectopic sprouts and a lack 
of vascular lumen at 48 hpf (Fig. 14 B´, C´, D´). Remarkably, ectopic sprouting in the 
Fig. 13. Oversprouting and vascular 
branch point defects in ccm2m201 mutant 
rescued by knock-down of klf2. (A-C) 
Shown are subintestinal veins (SIV) of 
different genotypes marked by the 
endothelial reporter line Tg(kdrl:GFP)s843 at 
72 hpf. (B-D) SIVs (arrowhead) exhibit 
ectopic sprouts (arrow) in ccm2m201 mutans. 
(C-D) Knock-down of klf2a/b rescues 
branchpoints and sprouting phenotypes. 
Statistical data are means and S.E.M. ns, 
not significant; **, p<0.01; ***, p<0.001; 
****, p<0.0001. (for details see appendix). 
Scale bars, 25µm. 
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cerebral vasculature of ccm2m201 mutants was suppressed by the simultaneous knock-
down of klf2a and klf2b (Fig. 14 E-E´). Vascular lumen and blood flow could also be 
observed in some embryos. Since ccm mutants lack a functional circulatory system, I 
hypothesized that the observed phenotype might be due to hypoxia. To test this, I 
analyzed cerebral blood vessel development in zebrafish no-flow tnnt2ab109 mutants. 
Fig. 14. Cerebral blood vessel defects in 
different ccm mutants. (A,E) Dorsal 
views of the cerebral blood vessels in 
different genotypes marked by 
Tg(kdrl:GFP)s843 at 48 hpf. (B-D) Vascular 
oversprouting in ccm2m201, krit1ty219, and 
hegm552 mutants (red arrowheads). (E) 
Rescue of sprouting and lumenization 
defects in ccm2m201 mutants by knock-
down of klf2a/b. pmCtA, posterior 




Similar to hegm552, krit1ty219c, and ccm2m201, tnnt2ab109 mutant cerebral blood vessels 
exhibit extensive vascular sprouts and vascular lumenization defects (Fig. 15 B-B´, 
n=5/5 embryos). 
 
Taken together, knock-down of klf2a and klf2b not only rescued increased 
endocardial cell number but also ectopic sprouting of the cerebral blood vessels in 
zebrafish ccm mutants, possibly in part by re-establishment of blood flow, and therefore 
vascular lumen formation. 
 
4.5 An anti-angiogenic activity of Ccm proteins contributes to normal 
cardiovascular development in zebrafish 
 
4.5.1 A loss of Ccm proteins triggers a VEGF-dependent angiogenic activity in 
endocardial cells 
Angiogenesis is the formation of new blood vessels from pre-existing vessels. 
Proliferation and sprout formation of endothelial cells drive this process. Studies in EC 
culture have shown that  angiogenesis signaling activity is increased upon loss of Ccm 
proteins (Wustehube et al., 2010; Zhu et al., 2010). In human patients, cerebral 
cavernous malformation lesion growth was found to correlate with increased circulating 
Fig. 15. Cerebral blood vessel defects in 
tnnt2ab109 mutants. (A,B) Dorsal views of 
the cerebral blood vessels marked by 
Tg(kdrl:GFP)s843 at 48 hpf. (B´) Vascular 
oversprouting in tnnt2ab109 mutants (red 
arrowheads). Scale bars, 25µm
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concentrations of VEGF, a prowth factor required for angiogenesis (Jung et al., 2003). 
Since the cardiovascular defects and microarray data suggested ongoing, active 
angiogenesis in ccm mutants, I investigated whether elevated angiogenesis signaling 
Fig. 16. Increased VEGF signaling is 
involved in ccm mutant phenotypes. (A-
E) Shown are hearts of different genotypes 
marked by the endocardial reporter line 
Tg(kdrl:GFP)s843 (green) and Actin (red) at 
48 hpf. (A´-E´) Details showing single 
confocal z-stacks of the atrioventricular 
canal (AVC). Endocardial cushion cells are 
marked by Actin (inverted image, red 
asterisks). (F) Endocardial cell numbers are 
significantly reduced in PTK787 treated 
ccm2m201 and hegm552 mutants compared to 
untreated mutants. Statistical data are 
means and S.E.M. ns, not significant; *, 
p<0.05; **, p<0.01; ***, p<0.001; ****, 




was involved in the ccm2 mutant phenotype. Using a pharmacological approach, I 
inhibited the VEGF signaling pathway using the compound PTK787 (Chan et al., 
2002). Pharmacological inhibition of VEGF signaling during different developmental 
periods helped to determine a critical time window between 15-17 hpf during which the 
inhibition of VEGF signaling could rescue the cardiac phenotypes of hegm552 (n=6/8 
mutants identified by genotyping), krit1ty219c (n=7/8 mutants identified by genotyping), 
or ccm2m201 (n=8/8 mutants identified by genotyping) mutants at 48hpf (Fig. 16). 
Similar to the knock-down of klf2a/b, PTK787-treated mutant embryos developed 
normal cardiac cushions consisting of compact, cuboidal endocardial cells. 
Additionally, cardiac looping occured normally, and the ventricular myocardium 
exhibited a compact actin-rich myofibrilar network (Fig. 16 C-E). Furthermore, cell 
counts revealed a reduction of endocardial cell numbers comparable to wild-type 
embryos in hegm552 and ccm2m201 mutants treated with PTK787 (wt, n=3 embryos; 
average cell number=144,7; S.E.M. 1,202; hegm552, n= 2 embryos; average cell 
number=219,5; S.E.M. 3,5; ccm2m201, n=3 embryos; average cell number=205,3; S.E.M. 
6,692; hegm552 + PTK787, n=3 embryos; average cell number=170,3; S.E.M. 12; 
ccm2m201 + PTK787, n=4 embryos; average cell number=162,5; S.E.M. 3,797). Due to 
the complete cardiac rescue, including blood flow in ccm mutants, it was nescessary to 
genotype these embryos. Moreover, I could show that VEGF signaling was dispensable 
for normal endocardial proliferation, since the inhibition with PTK787 had no impact 
on endocardial cell numbers at 48 hpf (wt, n=3 embryos; average cell number=144,7; 
S.E.M. 1,202; wt + PTK787, n=3 embryos; average cell number=146,7; S.E.M. 14,52) 
(Fig. 16 F) (Dietrich et al., 2014). Intriguingly, at 15-17 hpf the zebrafish heart is not 
yet formed and endocardial and myocardial progenitor cells are located as bilateral 
populations in the anterior lateral plate mesoderm (ALPM). Nevertheless, hegm552, 
krit1ty219c, or ccm2m201 mutant hearts were rescued as a consequence of the early 
PTK787 treatment. 
Taken together, these data showed that there is excessive VEGF-dependent 
angiogenesis in ccm mutants.	   Therefore, one function of Ccm proteins is to control 





4.5.2 Vascular defects are due to elevated VEGF-dependent angiogenesis in ccm 
mutants  
 
To examine whether increased angiogenesis signaling was responsible for the vascular 
phenotype in ccm mutants, I treated ccm2m201 mutant embryos between 24-48 hpf with 
PTK787 (12,5µM). Analysis of the lateral dorsal aorta (LDA) showed that the increased 
endothelial cell number of this vessel was rescued upon inhibition of VEGF signaling 
(Fig. 17, wt, n=3 embryos; average cell number=57,6; S.E.M. 1,45; ccm2m201, n=3 
embryos; average cell number=83; S.E.M. 1,53; ccm2m201 + PTK787, n=3 embryos; 
average cell number=62; S.E.M. 1,53). 
Cerebral blood vessel are highly sensitive to VEGF signaling. To avoid that an early 
inhibition of VEGF signaling may affect proper cerebral vascular development, I treated 
WT and ccm2m201 mutant embryos at 48 hpf, a timepoint at which the head vasculature 
is already established. Treatment with PTK787 between 48-49 hpf had no obvious 
effect on cerebral blood vessels in wild-type embryos (Fig. 18 A-A´´´), whereas the 
short inhibition was sufficient to inhibit ectopic vascular sprout formation in ccm2m201 
mutants (Fig. 18 B´´). Intriguingly, ECs of the cerebral vessels started sprouting upon 
the removal of the VEGF inhibitor PTK787 within 1 hour (Fig. 18 B´´´). In summary, I 
found that Ccm complex proteins prevent aberrant pro-angiogenic VEGF signaling in 
endocardial and endothelial cells. 
Fig. 17. VEGF inhibition rescues the vascular phenotype in 
ccm2m201 mutants. Treatment of ccm2m201 mutants with PTK787 
between 24-48 hpf rescues the increased cell number of the lateral 
dorsal aorta.	   Statistical data are means and S.E.M. ns, not 





4.5.3 Klf2 up-regulation is independent of the VEGF signaling pathway in ccm2 
mutants 
 
Because either klf2a/b knock-down or inhibition of VEGF signaling rescued the 
cardiovascular phenotype of ccm mutants, I next tested whether Klf2 expression is 
regulated by VEGF signaling (or vice versa). Klf2a/b mRNA levels were measured in 
PTK787- treated WT and ccm2m201 mutant embryos. RT-qPCR analyses showed that 
inhibition of the VEGF signaling pathway did not affect klf2a/b mRNA expression in 
either WT or ccm2m201 mutants (Fig. 19). Thus, Klf2 is not regulated by VEGF but 
seems rather to act upstream or in parallel of VEGF signaling. 
 
 
Fig. 18. Elevated VEGF signaling causes ectopic sprout formation in the cerebral vasculature of 
ccm2m201 mutants. (A,B) Dorsal views onto cerebral blood vessels in wild-type and ccm2m201 mutants 
marked by Tg(kdrl:GFP)s843 between 48-50 hpf. (A-A´´´) Treatment with PTK787 between 48-49 hpf 
has no effect on blood vessels in WT. In ccm2m201 mutants, blood vessels exhibit extensive sprout 
formation (B´, red arrowheads). Treatment with PTK787 significantly reduced the oversprouting 
phenotype (B´´). (B´´´) Reoccurence of ectopic sprouts within 1hr after removal of the inhibitor (red 




4.6 Klf2 up-regulation in endothelial cells involves aberrant β1 
integrin signaling 
	  
Given that neither VEGF signaling nor blood flow regulates Klf2 expression in ccm 
mutants suggested that other mechanisms might be involved in the induction of klf2a/b 
mRNA expression. Previous studies showed that CCM proteins play an important role 
in the regulation of β1 integrin signaling (Faurobert et al., 2013) by interacting with and 
stabilizing the negative regulator integrin cytoplasmic domain-associated protein-1 
(ICAP-1) (Faurobert et al., 2013; Hilder et al., 2007; Zawistowski et al., 2005; Zhang et 
al., 2001). Therefore, we tested whether Klf2 levels are changed upon knock-
down of β1 integrin. Loss of CCM proteins in HUVECs resulted in elevated KLF2 
expression levels, which could be suppressed by simultaneous depletion of ITGB1 
(Renz et al., 2015). 
To verify the role of β1 integrin signaling in ccm pathology in an animal model, I 
injected a morpholino against β1 integrin (itgb1b; 6,3ng) in zebrafish ccm2m201 mutants 
(Ablooglu et al., 2010). Similar to the knock-down of klf2a/b, the loss of Itgb1b rescued 
the cardiac phenotypes of ccm2m201 mutants including cushion formation and chamber 
morphogenesis (n=5/5 ccm2m201 mutants identified by genotyping; Fig. 20 C-C`) at 48 
hpf. 
Fig. 19. Klf2 up-regulation is independent of VEGF 
signaling in ccm2 mutants. PTK787 treatment between 15-48
hpf does not affect the elevated expression levels of klf2a and 
klf2b mRNA in ccm2m201 mutants as validated by RT-qPCR.
Statistical data are means and S.E.M. ns, not significant;  *, 




In a complementary approach, I injected a morpholino against the negative regulator 
ICAP-1 (icap-1; 8,3ng) in wild-type embryos to test whether increased β1 integrin 
signaling is responsible for the cardiovascular phenotype in ccm2m201 mutants. Indeed, 
Fig. 21. Loss of ICAP1 causes phenotypes similar to ccm2m201 in cranial blood vessel at 30 hpf. 
(A-C) Lateral views of different genotypes marked by Tg(kdrl:GFP)s843. (B) Dilation of the primordial 
midbrain channel (PMBC, arrow) and of the primitiv internal carotid artery (PICA, arrowhead) in 
ccm2m201 mutants. (C) Knock-down of ICAP1 phenocopies the ccm2m201 mutant phenotype. Scale bars, 
50µm 
Fig. 20. Knock-down of itgb1b rescues 
cardiac phenotypes in ccm2m201 mutants.	   
(A-C) Shown are hearts of different 
genotypes marked by the endocardial 
reporter line Tg(kdrl:GFP)s843 (green) and 
Actin (red) at 48 hpf. Details showing single 
confocal z-stacks of the atrioventricular 
canal (AVC). Endocardial cushion cells are 
marked by Actin (A´-E´, inverted image, red 
asterisks). (C-C´) Reduction of itgb1b 
mRNA levels rescues cardiac defects 
including chamber differentiation and 
cardiac cushion formation in ccm2m201 
mutants. Scale bars, 25µm 
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knock-down of ICAP-1 caused a dilation of the primordial midbrain channel (PMBC, 
arrow) and of the primitiv internal carotid artery (PICA, arrowhead) (Fig. 21 C) at 30 
hpf similar to the phenotype observed in ccm2m201 mutants (Fig. 21 B).  
Taken together, these results suggested that aberrant β1 integrin signaling has a role 
in ccm mutants upon loss of the ICAP1-CCM complex. 
 
4.7 Epidermal growth factor-like domain 7 (EGFL7) as a mediator of 
pro-angiogenic Klf2 activity in endocardial and endothelial cells  
	  
4.7.1 Klf2 mediates increased VEGF-dependent angiogenesis via Egfl7 in 
ccm2m201 mutants 
 
The finding that egfl7 has a putative binding site for Klf2 in its promoter region (Harris 
et al., 2010) and is involved in angiogenesis by binding to various receptors in the 
extracellular matrix (ECM), e.g. integrins (Nikolic et al., 2013) or the Notch pathway 
(Nichol and Stuhlmann, 2012; Schmidt et al., 2009), raised the hypothesis that elevated 
Klf2 levels may result in an overexpression of egfl7 that might contribute to the ccm 
phenotype.  
In zebrafish, cardiac microarray analysis and RT-qPCR experiments of whole 
embryonic tissue, done in collaboration with Dr. Cécile Otten, revealed significantly 
increased egfl7 mRNA levels in ccm2m201 mutants compared to wild-type embryos, 
which can be reduced by the injection of klf2a/b MOs (Fig. 22 A). Conversely, the 
overexpression of either klf2a [Tg(hsp70l:klf2a_IRES_GFP)md8] or of klf2b 
[Tg(hsp70l_klf2b_IRES_GFP)md9] was sufficient to increase egfl7 mRNA expression 
levels, validated by RT-qPCR analysis (Fig.22 A). To further investigate the role of 
egfl7 in ccm2m201 mutant cardiovascular malformations, I knocked-down Egfl7, which 
rescued the ccm2m201 mutant cardiac cushion and dilation defects (n=15/24 mutants 
identified by genotyping; Fig. 22 D-D´). Moreover, the cerebral ectopic sprouts were 
suppressed in ccm2m201 mutants (n=5/5 mutants identified by genotyping; Fig. 23 C-C´), 
even in the absence of blood flow due to a failure of cardiac recovery in some ccm2m201 
mutant embryos (n=3/3; Fig. 23 D-D´). This finding is intriguing, since tnnt2ab109 
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mutants which also lack blood flow, exhibit ectopic sprouts of the cerebral vasculature 
(Fig. 15 B´). Together, these results suggested that Klf2 mediates increased VEGF-




Fig. 22. Misregulation of the angiogenic signaling factor Egfl7 is involved in the zebrafish 
ccm2 mutant phenotype. (A) Loss of Ccm2 or overexpression of klf2a/b in 
Tg(hsp70l:klf2a_IRES_GFP)md8 or Tg(hsp70l:klf2b_IRES_GFP)md9 transgenic embryos 
increased egfl7 mRNA levels as validated by RT-qPCR. (B-D) Shown are hearts of different 
genotypes marked by the endocardial reporter line Tg(kdrl:GFP)s843 (green) and Actin (red) at 48 
hpf. (B´-D´) Details showing single confocal z-stacks of the atrioventricular canal (AVC). 
Endocardial cushion cells are marked by Alcam (inverted image, red asterisks). Knock-down of 
egfl7 rescues cardiac cushion development and chamber morphogenesis in ccm2m201 mutants. 
Statistical data are means and S.E.M. ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001; 






4.7.2 Klf2a/b and Egfl7 genetically interact to promote cardiovascular 
malformation defects in ccm2m201 mutants 
 
To test whether klf2a/b and egfl7 genetically interact in a common pathway in ccm 
mutants, I injected low doses of either klf2a/b MOs (2,5ng each) or egfl7MO (0,3ng) 
into ccm2m201 mutants. Whereas single injections did not rescue the lumenization 
defects of the intersegmental vessels (ISVs) of ccm2m201 mutants (no rescue among 
n>50 ccm2m201 mutants tested for each MO; Fig. 24 C,D), a combination of klf2a/b MOs 
and egfl7 MO re-established proper intersegmental vessel lumen formation (n=19/21 
mutants identified by genotyping; Fig. 24 E). 
Fig. 23. Rescue of extensive sprout 
growth and vascular lumen formation 
in ccm2m201 mutants by knock-down of 
egfl7. (A,D) Dorsal views of the cerebral 
blood vessels in different genotypes 
marked by Tg(kdrl:GFP)s843 at 48 hpf. 
(A´-D´) Details of the cerebral 
vasculature. (C-C`) Knock-down of egfl7 
with cardiac rescue (lumen formation, 
red bracktes). (D-D´) Knock-down of 
egfl7 without cardiac rescue in ccm2m201 
mutants. Scale bars, 25µm. 
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In a complemetary effort, I injected egfl7 MO into wild-type and ccm2m201 mutants 
and Dr. Cécile Otten measured klf2a/b mRNA levels by RT-qPCR to examine whether 
egfl7 activity affects klf2a/b expression. Indeed, analysis of egfl7 morphants and 
ccm2m201 mutant; egfl7 morphants showed a reduction of klf2a and klf2b mRNA levels 
in both WT and ccm2m201 mutants upon knock-down of egfl7 (Fig. 24 E). Thus, Klf2 
may not only regulate Egfl7, but in turn Egfl7 may affect klf2 mRNA expression.  
Fig. 24. Klf2a/b and Egfl7 genetically 
interact to regulate vascular lumen 
formation of the intersegmental blood 
vessels. (A-E) Shown are intersegmental 
blood vessels marked by Tg(kdrl:GFP)s843 
at 48 hpf. (B) Lack of intersegmental 
vessels in ccm2m201 mutants (arrow). (C-D) 
Low doses of klf2a/b MOs or egfl7 MO do 
not rescue the lumenization defects 
(arrows). (E) Triple-injection of klf2a/b 
MOs and egfl7 MO completely rescues 
lumenization defects (arrowheads). (F) 
Knock-down of egfl7 affects klf2a and 
klf2b mRNA levels in WT and ccm2m201 
mutants as detected by RT-qPCR. 
Statistical data are means and S.E.M. ns, 
not significant;  *, p<0.05; **, p<0.01; 
***, p<0.001. (for details see appendix). 
Scale bars, 25µm. 
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Taken together, these results showed that Klf2 and Egfl7 act together in the 






In my study, I showed that the cardiovascular defects in zebrafish ccm mutants are 
caused by a β1 Integrin-Klf2-dependent up-regulation of VEGF angiogenesis signaling 
in endothelial and endocardial cells. Furthermore, I showed that the pro-angiogenic 
activity of Klf2 is mediated by the stimulation of egfl7 expression and that klf2 
expression in CCM-deficient cells is independent of blood flow (Fig. 25). 
	  
	  
5.1 The CCM protein complex prevents extensive pro-angiogenic 
Klf2 activity in endocardial and endothelial cells 
	  
During vascular development, the CCM complex plays a major role in regulating 
vascular lumen formation, vascular integrity, and junctional stability (Hogan et al., 
2008; Kleaveland et al., 2009; Lampugnani et al., 2010; Stockton et al., 2010; 
Whitehead et al., 2009). However, these findings could not explain why only small 
capillary veins are affected by cavernoma formation in patients and in mice. Compared 
to arteries, veins have a wider inner diameter and decreased blood pressure. 
Furthermore, arteries and veins differ from each other by their genetic program. This 
Fig. 25. Model for CCM/ICAP1–
dependent pro-angiogenic activity via β1 
integrin, Klf2, and Egfl7. (A) The 
CCM/ICAP-1 complex prevents pro-
angiogenic β1 integrin signaling in 
endothelial/endocardial cells. (B) The loss of 
the CCM/ICAP-1 complex causes elevated 
β1 integrin activity, resulting in increased 
angiogenesis via Klf2 and Egfl7. 
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genetic program may, in part, be regulated by CCM proteins and blood flow. Genes 
which are normally suppressed in venous tissue, are expressed upon loss of the CCM 
complex and may result in the formation of CCMs. Among several blood flow-
regulated genes, the zinc-finger transcription factor KLF2 plays an important role in 
blood vessel biology. In endothelial cells, Klf2 activity is involved in vascular tone 
regulation (Dekker et al., 2005; Parmar et al., 2006; SenBanerjee et al., 2004), 
inflammation	  (Boon et al., 2007; Egorova et al., 2011; Fledderus et al., 2007; Helbing et 
al., 2011), thrombosis (Allen et al., 2011; Lin et al., 2005), oxidative stress (Dekker et 
al., 2006; Fledderus et al., 2008; Lee et al., 2012), endothelial barrier function (Lin et 
al., 2010b; Shi et al., 2013), and endothelial morphology (Boon et al., 2010; Dekker et 
al., 2006). Previous studies have shown that KLF2 has a vasoprotective function in the 
vasculature, dependent on blood flow patterns (Dekker et al., 2005; Huddleson et al., 
2005; Parmar et al., 2006). Klf2 activity can be modulated at different levels, including 
at the transcriptional (Wu et al., 2011) and posttranscriptional level (Wu et al., 2011), or 
by posttranslational modifications (Wang et al., 2010a; Young et al., 2009). In contrast, 
several lines of evidence suggest a pro-angiogenic function of Klf2 in vascular biology. 
During zebrafish aortic arch blood vessel development, Klf2 regulates a signaling 
cascade involved in the expression of the endothelial-specific miR126, which promotes 
VEGF-dependent angiogenesis (Nicoli et al., 2010) 
Based on the results obtained from the zebrafish cardiac microarray, I found that the 
shear-stress sensitive transcription factors klf2a and klf2b are up-regulated in zebrafish 
upon loss of Ccm2. These results were confirmed independently by collaborators 
working with CCM2-depleted HUVECs and iCCM2 knock-out mice (Renz et al., 
2015), which demonstrates that this mechanism is conserved in higher vertebrates. This 
finding is intriguing since zebrafish ccm mutants fail to generate a functional circulatory 
system due to vascular lumen defects. Klf2 expression in ccm mutants should be 
blocked as in silent heart (tnnt2a) mutants. Furthermore, I could show that the up-
regulation of klf2a and klf2b is necessary for causing CCM-dependent cardiovascular 
defects in zebrafish.  
Whereas loss of VEGF signaling activity has no effect on endocardial cell number in 
WT embryos (Dietrich et al., 2014), elevated Vegf-dependent angiogenesis signaling in 
endocardial cells resulted in the endocardial overproliferation phenotype in ccm 
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mutants. Since Heg, Krit1, and Ccm2 may act together in a complex, a lack of either 
one of these proteins may cause a break-down of the entire Ccm complex. This 
hypothesis is supported by the fact, that these mutants have similar cardiovascular 
phenotypes. Endocardial and endothelial overproliferation in zebrafish hegm552, 
krit1ty219c, and ccm2m201 mutants were either rescued by Klf2 knock-down or by 
inhibition of VEGF signaling, arguing for a pro-angiogenic activity of Klf2. 
Furthermore, unchanged expression levels of klf2 upon pharmacological inhibition of 
VEGF signaling showed that Klf2 acts upstream of the VEGF signaling pathway. In 
addition, blocking VEGF signaling prior to heart tube formation and the onset of blood 
flow was sufficient to rescue the myocardial and endocardial defects in ccm mutants 
which shows that Klf2 regulates Vegf signaling in endocardial progenitor cells. In sum, 
the CCM protein complex regulates VEGF-dependent angiogenesis via the shear-stress 
responsive transcription factor Klf2 in a manner that is independent of flow in 
endocardial and endothelial cells.  
CCMs are characterized by thin-walled, dilated blood vessels that resemble the 
primordial midbrain channel (PMBC), primitiv internal carotid artery (PICA), and the 
lateral dorsal aorta (LDA) phenotype of zebrafish ccm mutants. Additionally, 
endothelial cells of cavernoma lack associated vascular smooth muscle cells (VSMCs) 
in patients (Shenkar et al., 2008b; Shenkar et al., 2008a) and in mice (Cunningham et 
al., 2011). This finding is reminiscent of the observation that KLF2-overexpressing or 
shear-stress stimulated HUVECs secrete extracellular vesicles containing miR143/145 
to control gene expression in neighbouring smooth muscle cells (Hergenreider et al., 
2012). Therefore, overexpression of KLF2 in endothelial cells may explain the lack of 
vascular smooth muscle cells in patients. For cardiac development, it will be important 
to investigate whether this mechanism is also involved in endocardial-myocardial 
interaction. 
Furthermore, it has been shown that cavernoma in human patients exhibit areas with 
proliferative activity of endothelial cells (Notelet et al., 1997). However, the correlation 
between elevated KLF2 expression levels and CCM formation in human patients 
remains to be elucidated. A possible explanation for the venous-specific defects in mice 
and in patients may come from the role of KLF2 in the endothelium. Klf2 is highly 
expressed in regions of high shear-stress, e.g. the carotid artery, where it has a 
Discussion 
84 
vasoprotective function. Therefore, elevated KLF2 activity would not enhance 
vasoprotection in these vessels. In contrast, in low-flow blood vessels, like venous 
capillaries, Klf2 is not expressed. An up-reguation of Klf2 due to a loss of CCM 
proteins may induce signaling cascades including VEGF signaling that lead to cerebral 
cavernous malformation defects. 
In addition to VEGF signaling, a recent study demonstrated that postnatal 
endothelial-specific deletion of the CCM1 gene in mice induced a TGFβ-dependent 
endothelial-to-mesenchymal transition (EndMT), which contributes to the development 
of vascular malformations (Maddaluno et al., 2013). Intriguingly, Klf2 and TGFβ 
signaling act together during embryonic cardiac, and adult vascular development (Boon 
et al., 2007; Egorova et al., 2011). In this context, it will be important to investigate the 
role of Klf2 in TGFβ-mediated vascular malformations. 
 
5.2 The instructive role of β1 integrin signaling in Klf2-dependent 
cardiovascular defects 
	  
Integrins are transmembrane cell adhesion receptors that allow the communication 
between the extracellular matrix (ECM) and intracellular signaling pathways (Hynes et 
al., 2002) involved in actin cytoskeleton organization (Shibue et al., 2013), cell 
adhesion (Papusheva et al., 2010), ECM deposition (Schwarzbauer et al., 2011), and 
cell polarity (Cox et al., 2001; Etienne-Manneville et al., 2001). Previous studies 
indicated that β1 integrin signaling is involved in CCM-related vascular defects by 
interacting with the negative regulator ICAP-1 through KRIT1 (Hilder et al., 2007; 
Zawistowski et al., 2005; Zhang et al., 2008). KRIT1 binds to and stabilizes ICAP-1 to 
prevent talin-mediated activation of the β1 integrin signaling pathway. Furthermore, in 
vitro and in vivo studies showed that a loss of either ICAP-1, KRIT1, or CCM2 
destabilizes the entire ICAP-1-CCM complex and results in increased β1 integrin 
activation and actin stress fiber formation, while simulatenous depletion of β1 integrin 
in HUVECS abolishes actin stress fiber formation (Faurobert et al., 2013). 
The flow-inpendent up-regulation of KLF2 in ICAP-1-, KRIT1-, or CCM2-depleted 
HUVECS is mediated by elevated β1 integrin signaling (Renz et al., 2015). 
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Additionally, the cardiovascular defects in zebrafish ccm2 mutants were rescued by 
knock-down of β1 integrin implying a conserved mechanism in the regulation of Klf2 
by β1 integrin signaling. Complementary to these effects, the knock-down of icap-1 in 
zebrafish recapitulate the early vascular ccm2 phenotype. However, the dilation of the 
heart chambers could not be observed in these icap-1 morphant embryos. 
β1 integrin signaling induces RhoA-dependent stress fiber formation by a crosstalk 
with Scr-family kinases and Rho-family GTPases (Huveneers et al., 2009). The CCM 
proteins have been shown to regulate RhoA activation and ROCK activity (Borikova et 
al., 2010; Chan et al., 2010; Stockton et al., 2010; Whitehead et al., 2009). In brain 
endothelial cells, CCM2 binding to the Smad ubiquitin regulatory factor-1 (Smurf1) 
increases Smurf1-mediated degradation of RhoA (Crose et al., 2009). Remarkably, 
Smurf1 is also required for the ubiquitination and degradation of KLF2 in human lung 
cancer H1299 cells (Xie et al., 2011), suggesting a potential role of the CCM complex, 
at least of CCM2, in regulating KLF2 protein levels by Smurf1-mediated degradation. 
Intriguingly, shear-stress induced overexpression of KLF2 in HUVECs also results in 
actin stress fiber formation (Boon et al., 2010). These actin stress fibers are assembled 
in the direction of flow and result in an elongation of endothelial cells along the flow in 
a Rho kinase-independent mechanism (Boon et al., 2010). Thus, the CCM complex may 
play a previously unappreciated role in the onset of CCM-dependent cardiovascular 
defects by the regulation β1 integrin-dependent induction of KLF2 via ICAP-1. 
Furthermore, CCM2 may regulate KLF2 protein levels by Smurf1-mediated 
degradation. However, whether CCM2 interacts with Smurf1 in this context remains to 
be elucidated.  
So far, the molecular mechanism by which β1 integrin regulates Klf2 expression are 
unknown and need further investigation. Moreover, it is not known whether other 
integrins besides β1 integrin are also involved in KLF2 regulation at different 






5.3 Klf2 mediates pro-angiogenic activity via Egfl7 
 
During vascular development, the VEGF signaling pathway can be regulated by pro-
angiogenic miR-126 activity or by inhibition of the Notch signaling pathway. The role 
of the transcription factors Klf2a and Klf2b in this context is largely unknown.  
Knock-out experiments in mice showed that a loss of EGFL7 caused severe vascular 
defects (Schmidt et al., 2007). These phenotypes were similar to the loss of miR-126. 
Endothelial-specific deletion of EGFL7, without affecting miR-126 expression, showed 
that knock-out mice were phenotypically normal, whereas the knock-out of miR-126 
recapitulated the previously described Egfl7 vascular defects (Kuhnert et al., 2008). 
Thus, the vascular defects were attributed to the loss of miRNA-126 rather than to loss 
of EGFL7. In zebrafish, Klf2 regulates VEGF-dependent angiogenesis during aortic 
arches development by miRNA-126a (Nicoli et al., 2010). However, qRT-PCR analyses 
done by David Hassel´s lab showed that neither miR-126a nor miR-126b were up-
regulated in zebrafish ccm2m201 mutants compared to wild-type embryos (Renz et al., 
2015).  
Together, here I showed that Klf2 positively regulates the expression of the 
endothelial-specific gene egfl7, the host gene of miR-126, and that overexpression of 
this factor causes the VEGF-dependent cardiovascular defects in zebrafish ccm mutants 
independently of miR-126. 
Several lines of evidence suggest an antagonistic role of Egfl7 in VEGF-dependent 
angiogenesis via the negative regulation of the Notch signaling pathway (Nichol et al., 
2010). Endothelial overexpression of EGFL7 in mice caused partial lethality, 
hemorrhaging, cardiac morphogenesis defects, and a reduced number of major cranial 
blood vessels, findings which are similar to the cardiovascular phenotypes in zebrafish 
ccm mutants. Since the vascular defects in patients and in mice occur in mature venous 
blood vessels, venous-specific expression of Egfl7 and arterial-specific expression of 
components of the Notch signaling pathway argue against a Egfl7-Notch-mediated 
regulation of the VEGF signaling pathway in veins (Bambino et al., 2014; Poissonnier 
et al., 2014; Villa et al., 2001). Furthermore, the inhibition of Notch signaling in 
zebrafish by morpholino injection against RbpSuH (a transcriptional co-activator) did 
not recapitulate the Ccm cardiovascular defects (Siekmann et al., 2007). In follow-up 
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experiments, analyses of zebrafish hegm552, krit1ty219c, and ccm2m201 mutant using 
different transgenic reporter lines for components of the Notch signaling pathway will 
be necessary to exclude or to validate whether angiogenesis defects upon loss of Ccm 
are Notch-dependent processes. 
Besides the regulation of the VEGF signaling pathway by miR-126 or by inhibition 
of the Notch signaling pathway, Egfl7 may also affect angiogenesis by activating the β3 
integrin signaling pathway (Nikolic et al., 2013; Takeuchi et al., 2014). In HUVECs, 
EGFL7 binds specifically to αvβ3 integrin via its RGD motif and positively affects 
blood vessel formation (Nikolic et al., 2013). Furthermore, Takeuchi et al. demonstrated 
that VEGF-induced up-regulation of phospho-Akt and phospho-Erk(1/2) was 
suppressed by knock-down of EGFL7. Hence, Egfl7 may regulate VEGF-dependent 
angiogenesis by activating β3 integrin signaling (Takeuchi et al., 2014). 
Transferred to a pathological condition, a loss of Ccm complex proteins could induce 
abberant β1 integrin activity, leading to increased Klf2 expression, and subsequently 
elevated Egfl7 expression. Egfl7 overexpression in turn may activate β3 integrin 
signaling resulting in enhanced VEGF-dependent angiogenesis signaling.  
Fig. 26. Proposed model for Egfl7-dependent regulation of 
Klf2 via β3 integrin. The loss of the CCM/ICAP-1 complex 
induces β1 integrin-dependent up-regulation of Egfl7 via Klf2. 
In turn, Egfl7 may bind to β3 integrin and trigger Klf2 
expression via a positive feedback-loop. Hence, knock-down of 
Egfl7 may decrease β3 integrin-dependent expression of Klf2. 
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The finding that egfl7 knock-down in zebrafish significantly decreased klf2a/b 
expression levels (Results Fig.24E) implies that Klf2 may also be regulated, in part, by 
a Egfl7/β3 integrin-dependent mechanism. Double knock-down of klf2a/b and egfl7 by 
low-dose morpholino injection into ccm mutants support the idea that these factors act 
together in VEGF-dependent angiogenesis. Knock-down of β3 integrin in zebrafish may 
be the first step in assessing its potential role in the regulation of Klf2 (Fig. 26). 
 
5.4 Ectopic cerebral sprouts and vascular lumen formation in 
zebrafish ccm mutants 
	  
Investigations of primary defects in ccm-deficient cerebral blood vessels are 
complicated since ccm mutants lack a functional circulatory system. Blood flow is 
nescessary to supply organs with nutrients and oxygen for proper function. Hypoxia, an 
undersupply with oxygen, induces neoangiogenesis from quiescent blood vessels by 
activating the HIF-1 signaling pathway (Forsythe et al., 1996; Goldberg et al., 1994; Liu 
et al., 1995; Shweiki et al., 1992). In zebrafish silent heart (tnnt2a) mutants, which lack 
blood flow, I noticed ectopic sprout formation of cerebral blood vessels similar to the 
vascular phenotype in hegm552, krit1ty219c, and ccm2m201 mutants. Thus, this ectopic 
sprouting phenotype may be a secondary effect due to a lack of blood flow and hypoxia-
induced angiogenesis signaling. Strikingly, sprout formation was suppressed by 
knocking-down either klf2a/b, itgb1b, or egfl7 in ccm mutants. For instance, in ccm2m201 
mutant; egfl7 morphants, vascular sprout formation was suppressed (n=3/3 embryos) 
even in the absence of blood flow, indicating that hypoxia-induced angiogenesis may 
also be affected by the β1 integrin-Klf2-Egfl7 signaling cascade. It will be interesting to 
test whether the oversprouting phenotype in tnnt2a mutants can also be rescued by 
knock-down of either of these factors.  
As blood vessels in zebrafish tnnt2a mutants fail to form a vascular lumen, the 
partial rescue of the lumenization defects in ccm mutants injected with klf2a/b or egfl7 
morpholino may be attributed to a recovery of the heart, and therefore circulation of 
fluid within blood vessels rather than a rescue of the endothelial cells themself. In 
addition, ccm2m201 mutants injected with a combination of klf2a/b and egfl7 morpholino 
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exhibited cardiac rescue and circulating blood cells within the entire vascular network 
resulting in vascular lumen formation of intersegmental vessels. Hence, vascular 
lumenization defects in zebrafish ccm mutants may be a consequence of a failure in 




Further research is necessary to understand the biology of cerebral cavernous 
malformations. Pharmacological compound screens of known drugs may be a first step 
to identify new targets involved in Ccm-dependent diseases. The zebrafish, as an ideal 
model organism, allows to test many drugs in a short period of time. Subsequently, 
potential canditates can be tested in more disease relevant organisms, such as mice or 
rat.  
In addition, clonal studies of ccm-deficient endothelial cells in wild-type background 
are necessary to get a better understanding of how these cells behave under normal 
physiological conditions and whether they recapitulate the vascular defects observed in 
mice and human with respect to bleeding or cavernoma development.  
Genetic and molecular evidence from inheritable forms of aneurysms points to an 
involvement of aberrant TGF-β signaling in vascular pathologies (Pardali et al., 2010; 
Lindsay and Dietz, 2011). Since murine KLF2 knockout animals frequently present 
with aortic aneuryms (Kuo et al., 1997) and aberrant TGF-β signaling is involved in 
cerebral cavernous malformations (Maddaluno et al., 2013), future research should 
reveal whether the signaling pathway elucidated in this study, is relevant for other 













 Unpaired t-tests P value 
Fig. 9, 
endocardium 
wt vs ccm2 ***  P=0,0009 
wt vs ccm2;klf2abMO **  P=0,0047 
ccm2 vs ccm2;klf2abMO ***  P=0,0004 
 1-way ANOVA test P value 
Fig. 15F, 
endocardium 
wt vs ccm2 **  P=0,002 
wt vs wt + PTK787 n.s. P>0,999 
wt vs ccm2 + PTK787 n.s. P=0,971 
ccm2 vs ccm2 + PTK787 *   P=0,0174 
wt vs heg + PTK787 n.s. P=0,3781 
 wt vs heg  *** P=0,0009 
 heg vs heg + PTK787 * P=0,0229 
 Unpaired t-tests P value 
Fig.12D, LDA 
wt vs ccm2 ***  P=0,0003 
wt vs ccm2;klf2abMO n.s. P=0,74 
wt vs hsp70l:klf2a ** P=0,004 
ccm2 vs hsp70l:klf2a n.s. P=0,252 
ccm2 vs ccm2;klf2abMO ** P=0,004 
 Unpaired t-tests P value 
Fig.17, LDA 
wt vs ccm2 ***  P=0,0003 
wt vs ccm2 + PTK787 n.s. P=0,109 
ccm2 vs ccm2 + PTK787 ***  P=0,0006 
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 1-way ANOVA test P value 
Fig. 13D 
(branchpoints) 
wt vs ccm2 *  P=0,0198 
wt vs ccm2;klf2abMO n.s.  P=0,5214 
ccm2 vs ccm2;klf2abMO **  P=0,0036 
 1-way ANOVA test P value 
Fig. 13D 
(sprouts) 
wt vs ccm2 ****  P<0.0001 
wt vs ccm2;klf2abMO *  P=0,0108 
ccm2 vs ccm2;klf2abMO ****  P<0,0001 
 n= klf2a klf2b Mean SEM Mean SEM 
Fig. 
10H 
wt 4 1,002 0,033 1,004 0,052 
tnnt2aMO 5 0,740 0,046 0,831 0,040 
ccm2 5 1,779 0,073 1,740 0,046 
ccm2 + tnnt2aMO 4 1,804 0,051 1,343 0,023 
 n= klf2a klf2b Mean SEM Mean SEM 
Fig. 
6 
wt 4 1,002 0,033 1,004 0,052 
ccm2 5 1,779 0,073 1,740 0,046 




































wt vs tnnt2aMO * P=0,0257 n.s. P=0,0628 
wt vs ccm2 **** P<0,0001 **** P<0,0001 
wt vs ccm2;tnnt2aMO **** P<0,0001 *** P=0,0006 
tnnt2aMO vs 
ccm2;tnnt2aMO **** P<0,0001 **** P<0,0001 
ccm2 vs ccm2;tnnt2aMO n.s. P=0,990 **** P<0,0001 
 n= klf2a klf2b Mean SEM Mean SEM 
Fig. 
19 
wt 3 1,001 0,029 1,002 0,043 
ccm2 3 1,796 0,248 1,725 0,173 
wt + PTK787 3 0,925 0,030 1,054 0,062 
ccm2 + PTK787 3 1,713 0,163 1,666 0,039 





wt vs ccm2 * P=0,0225 ** P=0,0029 
wt vs wt + PTK787 n.s. P=0,9946 n.s. P=0,9933 
wt vs ccm2 + PTK787 * P=0,0395 ** P=0,0050 
ccm2 vs ccm2 + PTK787 n.s. P=0,9925 n.s. P=0,9893 
 n= egfl7 
Mean SEM 
Fig. 23A 
Heat-shock control 3 1,001 0,034 
hsp70l:klf2a_IRES_GFP 3 1,477 0,058 
hsp70l:kfl2b_IRES_GFP 3 1,9 0,14 
 1-way ANOVA test 
P value 
egfl7 


































wt 3 1 0,017 
ccm2 3 1,335 0,070 
ccm2 + klf2abMO 3 1,188 0,221 




wt vs ccm2 ** P=0,01 
wt vs ccm2;klf2abMO n.s. P=0,446 
ccm2 vs ccm2;klf2abMO n.s. P=0,561 
 n= klf2a klf2b Mean SEM Mean SEM 
Fig. 24E 
wt 3 1,000 0,002 1,000 0,021 
egfl7MO 3 0,742 0,003 0,724 0,037 
ccm2 3 2,033 0,046 1,406 0,113 
ccm2 + egfl7MO 3 1,160 0,073 0,921 0,067 





wt vs ccm2 **** P<0,0001 n.s. P=0,0691 
wt vs egfl7MO * P=0,0455 * P=0,0122 
wt vs ccm2 + egfl7MO n.s. P=0,2633 n.s. P=0,4358 
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